Frequencies for first 10,000 rows of pt variable in reac2011q2 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 11 0.11 0.11 ABDOMINAL DISCOMFORT | 23 0.23 0.34 ABDOMINAL DISTENSION | 8 0.08 0.42 ABDOMINAL HERNIA | 1 0.01 0.43 ABDOMINAL MASS | 1 0.01 0.44 ABDOMINAL PAIN | 57 0.57 1.01 ABDOMINAL PAIN LOWER | 6 0.06 1.07 ABDOMINAL PAIN UPPER | 37 0.37 1.44 ABDOMINAL STRANGULATED HERNIA | 1 0.01 1.45 ABDOMINAL TENDERNESS | 2 0.02 1.47 ABNORMAL BEHAVIOUR | 10 0.10 1.57 ABNORMAL DREAMS | 8 0.08 1.65 ABNORMAL LOSS OF WEIGHT | 1 0.01 1.66 ABNORMAL SENSATION IN EYE | 1 0.01 1.67 ABNORMAL WEIGHT GAIN | 1 0.01 1.68 ABORTION | 2 0.02 1.70 ABORTION INDUCED | 3 0.03 1.73 ABORTION SPONTANEOUS | 7 0.07 1.80 ABSCESS | 5 0.05 1.85 ABSCESS INTESTINAL | 1 0.01 1.86 ABSCESS JAW | 2 0.02 1.88 ABSCESS ORAL | 1 0.01 1.89 ACCESSORY AURICLE | 1 0.01 1.90 ACCIDENT | 2 0.02 1.92 ACCIDENT AT HOME | 1 0.01 1.93 ACCIDENT AT WORK | 1 0.01 1.94 ACCIDENTAL DEATH | 1 0.01 1.95 ACCIDENTAL DRUG INTAKE BY CHILD | 5 0.05 2.00 ACCIDENTAL EXPOSURE | 2 0.02 2.02 ACCIDENTAL OVERDOSE | 5 0.05 2.07 ACHROMOTRICHIA ACQUIRED | 1 0.01 2.08 ACNE | 5 0.05 2.13 ACQUIRED IMMUNODEFICIENCY SYNDROME | 1 0.01 2.14 ACTINOMYCOSIS | 2 0.02 2.16 ACTIVITIES OF DAILY LIVING IMPAIRED | 6 0.06 2.22 ACUTE CORONARY SYNDROME | 5 0.05 2.27 ACUTE GRAFT VERSUS HOST DISEASE | 7 0.07 2.34 ACUTE HEPATIC FAILURE | 1 0.01 2.35 ACUTE LEUKAEMIA | 1 0.01 2.36 ACUTE MYELOID LEUKAEMIA | 11 0.11 2.47 ACUTE MYOCARDIAL INFARCTION | 7 0.07 2.54 ACUTE PSYCHOSIS | 1 0.01 2.55 ACUTE RESPIRATORY DISTRESS SYNDROME | 4 0.04 2.59 ACUTE RESPIRATORY FAILURE | 3 0.03 2.62 ADENOCARCINOMA PANCREAS | 1 0.01 2.63 ADENOID CYSTIC CARCINOMA | 1 0.01 2.64 ADENOMA BENIGN | 1 0.01 2.65 ADENOVIRUS INFECTION | 1 0.01 2.66 ADENOVIRUS TEST POSITIVE | 1 0.01 2.67 ADNEXA UTERI MASS | 1 0.01 2.68 ADNEXA UTERI PAIN | 1 0.01 2.69 ADRENAL HAEMORRHAGE | 1 0.01 2.70 ADRENAL INSUFFICIENCY | 2 0.02 2.72 ADRENAL NEOPLASM | 1 0.01 2.73 ADVERSE DRUG REACTION | 6 0.06 2.79 ADVERSE EVENT | 4 0.04 2.83 ADVERSE REACTION | 4 0.04 2.87 AFFECT LABILITY | 2 0.02 2.89 AFFECTIVE DISORDER | 1 0.01 2.90 AGEUSIA | 1 0.01 2.91 AGGRESSION | 10 0.10 3.01 AGITATION | 17 0.17 3.18 AGRANULOCYTOSIS | 3 0.03 3.21 AIRWAY COMPLICATION OF ANAESTHESIA | 1 0.01 3.22 AKATHISIA | 2 0.02 3.24 ALANINE AMINOTRANSFERASE INCREASED | 20 0.20 3.44 ALCOHOL PROBLEM | 1 0.01 3.45 ALCOHOLISM | 1 0.01 3.46 ALLERGIC TRANSFUSION REACTION | 1 0.01 3.47 ALLERGY TO ARTHROPOD STING | 1 0.01 3.48 ALLERGY TO CHEMICALS | 1 0.01 3.49 ALOPECIA | 14 0.14 3.63 ALOPECIA SCARRING | 1 0.01 3.64 ALOPECIA UNIVERSALIS | 1 0.01 3.65 ALTERED STATE OF CONSCIOUSNESS | 8 0.08 3.73 AMAUROSIS FUGAX | 1 0.01 3.74 AMENORRHOEA | 2 0.02 3.76 AMMONIA INCREASED | 1 0.01 3.77 AMNESIA | 17 0.17 3.94 AMNIORRHEXIS | 1 0.01 3.95 AMNIOTIC FLUID VOLUME DECREASED | 1 0.01 3.96 AMPUTATION | 1 0.01 3.97 ANAEMIA | 48 0.48 4.45 ANAEMIA MACROCYTIC | 1 0.01 4.46 ANAEMIA OF MALIGNANT DISEASE | 1 0.01 4.47 ANAEMIA POSTOPERATIVE | 1 0.01 4.48 ANAESTHETIC COMPLICATION | 1 0.01 4.49 ANAL ABSCESS | 4 0.04 4.53 ANAL FISTULA | 2 0.02 4.55 ANAL HAEMORRHAGE | 1 0.01 4.56 ANAL PRURITUS | 1 0.01 4.57 ANAPHYLACTIC REACTION | 7 0.07 4.64 ANAPHYLACTIC SHOCK | 10 0.10 4.74 ANAPHYLACTOID REACTION | 1 0.01 4.75 ANAPHYLACTOID SHOCK | 1 0.01 4.76 ANASTOMOTIC HAEMORRHAGE | 1 0.01 4.77 ANGER | 6 0.06 4.83 ANGINA PECTORIS | 6 0.06 4.89 ANGINA UNSTABLE | 3 0.03 4.92 ANGIOEDEMA | 9 0.09 5.01 ANGIOPATHY | 1 0.01 5.02 ANGIOPLASTY | 1 0.01 5.03 ANGIOTENSIN CONVERTING ENZYME INCREASED | 1 0.01 5.04 ANHEDONIA | 34 0.34 5.38 ANKLE FRACTURE | 5 0.05 5.43 ANKYLOSING SPONDYLITIS | 1 0.01 5.44 ANOSMIA | 1 0.01 5.45 ANTI-INSULIN ANTIBODY | 1 0.01 5.46 ANTICHOLINERGIC SYNDROME | 2 0.02 5.48 ANTINUCLEAR ANTIBODY POSITIVE | 1 0.01 5.49 ANURIA | 3 0.03 5.52 ANXIETY | 91 0.91 6.43 ANXIETY DISORDER | 1 0.01 6.44 AORTIC ANEURYSM | 2 0.02 6.46 AORTIC ANEURYSM REPAIR | 1 0.01 6.47 AORTIC DILATATION | 1 0.01 6.48 AORTIC DISORDER | 1 0.01 6.49 AORTIC STENOSIS | 2 0.02 6.51 AORTIC SURGERY | 1 0.01 6.52 AORTIC VALVE DISEASE | 1 0.01 6.53 AORTIC VALVE INCOMPETENCE | 1 0.01 6.54 AORTIC VALVE SCLEROSIS | 1 0.01 6.55 AORTIC VALVE STENOSIS | 1 0.01 6.56 APATHY | 2 0.02 6.58 APHAGIA | 7 0.07 6.65 APHASIA | 11 0.11 6.76 APHONIA | 1 0.01 6.77 APHTHOUS STOMATITIS | 2 0.02 6.79 APLASIA PURE RED CELL | 1 0.01 6.80 APLASTIC ANAEMIA | 3 0.03 6.83 APNOEA | 2 0.02 6.85 APPARENT DEATH | 2 0.02 6.87 APPENDICITIS PERFORATED | 1 0.01 6.88 APPLICATION SITE ERYTHEMA | 1 0.01 6.89 APPLICATION SITE REACTION | 2 0.02 6.91 APPLICATION SITE VESICLES | 1 0.01 6.92 APRAXIA | 1 0.01 6.93 APTYALISM | 1 0.01 6.94 AREFLEXIA | 2 0.02 6.96 ARRHYTHMIA | 14 0.14 7.10 ARRHYTHMIA NEONATAL | 2 0.02 7.12 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 7.13 ARTERIAL INSUFFICIENCY | 1 0.01 7.14 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 7.15 ARTERIAL STENOSIS | 2 0.02 7.17 ARTERIAL THERAPEUTIC PROCEDURE | 1 0.01 7.18 ARTERIOSCLEROSIS | 8 0.08 7.26 ARTERIOSCLEROSIS CORONARY ARTERY | 4 0.04 7.30 ARTERY DISSECTION | 1 0.01 7.31 ARTHRALGIA | 59 0.59 7.90 ARTHRITIS | 12 0.12 8.02 ARTHRITIS BACTERIAL | 2 0.02 8.04 ARTHRODESIS | 1 0.01 8.05 ARTHROPATHY | 10 0.10 8.15 ASCITES | 6 0.06 8.21 ASPARTATE AMINOTRANSFERASE ABNORMAL | 2 0.02 8.23 ASPARTATE AMINOTRANSFERASE INCREASED | 11 0.11 8.34 ASPIRATION | 6 0.06 8.40 ASTERIXIS | 1 0.01 8.41 ASTHENIA | 57 0.57 8.98 ASTHENOPIA | 1 0.01 8.99 ASTHMA | 17 0.17 9.16 ATAXIA | 2 0.02 9.18 ATELECTASIS | 4 0.04 9.22 ATHERECTOMY | 1 0.01 9.23 ATRIAL FIBRILLATION | 28 0.28 9.51 ATRIAL SEPTAL DEFECT | 3 0.03 9.54 ATRIOVENTRICULAR BLOCK | 1 0.01 9.55 ATRIOVENTRICULAR BLOCK COMPLETE | 1 0.01 9.56 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 2 0.02 9.58 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 9.59 ATROPHIC VULVOVAGINITIS | 1 0.01 9.60 ATROPHY | 4 0.04 9.64 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 2 0.02 9.66 AUTOIMMUNE DISORDER | 1 0.01 9.67 AUTOIMMUNE THYROIDITIS | 4 0.04 9.71 AUTONOMIC NEUROPATHY | 1 0.01 9.72 AZOTAEMIA | 1 0.01 9.73 B-CELL LYMPHOMA | 1 0.01 9.74 B-CELL TYPE ACUTE LEUKAEMIA | 1 0.01 9.75 BACK DISORDER | 6 0.06 9.81 BACK INJURY | 2 0.02 9.83 BACK PAIN | 48 0.48 10.31 BACTERIAL INFECTION | 5 0.05 10.36 BALANCE DISORDER | 18 0.18 10.54 BARRETT'S OESOPHAGUS | 1 0.01 10.55 BASAL CELL CARCINOMA | 2 0.02 10.57 BASEDOW'S DISEASE | 2 0.02 10.59 BASILAR MIGRAINE | 1 0.01 10.60 BEDRIDDEN | 6 0.06 10.66 BENIGN BREAST NEOPLASM | 3 0.03 10.69 BENIGN COLONIC NEOPLASM | 1 0.01 10.70 BENIGN NEOPLASM OF THYROID GLAND | 2 0.02 10.72 BENIGN OVARIAN TUMOUR | 1 0.01 10.73 BILE DUCT CANCER | 1 0.01 10.74 BILE DUCT OBSTRUCTION | 4 0.04 10.78 BILE DUCT STONE | 2 0.02 10.80 BILIARY COLIC | 4 0.04 10.84 BILIARY DILATATION | 1 0.01 10.85 BILIARY DYSKINESIA | 2 0.02 10.87 BILIARY TRACT DISORDER | 1 0.01 10.88 BIOPSY CERVIX | 1 0.01 10.89 BIOPSY HEART | 1 0.01 10.90 BIOPSY TONGUE ABNORMAL | 1 0.01 10.91 BIPOLAR DISORDER | 4 0.04 10.95 BITE | 2 0.02 10.97 BLADDER CANCER | 3 0.03 11.00 BLADDER DISCOMFORT | 1 0.01 11.01 BLADDER DISORDER | 1 0.01 11.02 BLADDER NEOPLASM | 1 0.01 11.03 BLADDER SPASM | 1 0.01 11.04 BLADDER TRANSITIONAL CELL CARCINOMA | 1 0.01 11.05 BLAST CELL CRISIS | 1 0.01 11.06 BLASTOCYSTIS INFECTION | 1 0.01 11.07 BLEPHAROSPASM | 2 0.02 11.09 BLIGHTED OVUM | 1 0.01 11.10 BLINDNESS | 12 0.12 11.22 BLINDNESS TRANSIENT | 2 0.02 11.24 BLINDNESS UNILATERAL | 2 0.02 11.26 BLISTER | 4 0.04 11.30 BLOOD ALBUMIN DECREASED | 5 0.05 11.35 BLOOD ALCOHOL INCREASED | 1 0.01 11.36 BLOOD ALKALINE PHOSPHATASE INCREASED | 9 0.09 11.45 BLOOD AMYLASE INCREASED | 5 0.05 11.50 BLOOD BETA-D-GLUCAN INCREASED | 1 0.01 11.51 BLOOD BILIRUBIN INCREASED | 4 0.04 11.55 BLOOD CALCIUM DECREASED | 3 0.03 11.58 BLOOD CALCIUM INCREASED | 2 0.02 11.60 BLOOD CHLORIDE DECREASED | 1 0.01 11.61 BLOOD CHLORIDE INCREASED | 2 0.02 11.63 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 11.65 BLOOD CHOLESTEROL INCREASED | 7 0.07 11.72 BLOOD CREATINE INCREASED | 2 0.02 11.74 BLOOD CREATINE PHOSPHOKINASE ABNORMAL | 1 0.01 11.75 BLOOD CREATINE PHOSPHOKINASE INCREASED | 6 0.06 11.81 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 11.82 BLOOD CREATININE INCREASED | 12 0.12 11.94 BLOOD DISORDER | 2 0.02 11.96 BLOOD GLUCOSE ABNORMAL | 3 0.03 11.99 BLOOD GLUCOSE DECREASED | 2 0.02 12.01 BLOOD GLUCOSE FLUCTUATION | 1 0.01 12.02 BLOOD GLUCOSE INCREASED | 15 0.15 12.17 BLOOD GROWTH HORMONE DECREASED | 1 0.01 12.18 BLOOD HEAVY METAL INCREASED | 1 0.01 12.19 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 12.20 BLOOD IRON DECREASED | 1 0.01 12.21 BLOOD IRON INCREASED | 1 0.01 12.22 BLOOD LACTATE DEHYDROGENASE INCREASED | 5 0.05 12.27 BLOOD OSMOLARITY INCREASED | 1 0.01 12.28 BLOOD POTASSIUM DECREASED | 4 0.04 12.32 BLOOD POTASSIUM INCREASED | 5 0.05 12.37 BLOOD PRESSURE ABNORMAL | 1 0.01 12.38 BLOOD PRESSURE DECREASED | 13 0.13 12.51 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 12.52 BLOOD PRESSURE FLUCTUATION | 3 0.03 12.55 BLOOD PRESSURE INADEQUATELY CONTROLLED | 3 0.03 12.58 BLOOD PRESSURE INCREASED | 17 0.17 12.75 BLOOD PRESSURE SYSTOLIC INCREASED | 4 0.04 12.79 BLOOD SODIUM DECREASED | 4 0.04 12.83 BLOOD SODIUM INCREASED | 4 0.04 12.87 BLOOD TEST ABNORMAL | 1 0.01 12.88 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 12.90 BLOOD TRIGLYCERIDES INCREASED | 6 0.06 12.96 BLOOD UREA INCREASED | 4 0.04 13.00 BLOOD URIC ACID INCREASED | 3 0.03 13.03 BLOOD URINE PRESENT | 5 0.05 13.08 BODY HEIGHT DECREASED | 1 0.01 13.09 BODY MASS INDEX INCREASED | 3 0.03 13.12 BODY TEMPERATURE DECREASED | 1 0.01 13.13 BODY TEMPERATURE FLUCTUATION | 1 0.01 13.14 BODY TEMPERATURE INCREASED | 3 0.03 13.17 BONE DENSITY ABNORMAL | 2 0.02 13.19 BONE DENSITY DECREASED | 10 0.10 13.29 BONE DISORDER | 15 0.15 13.44 BONE INFARCTION | 2 0.02 13.46 BONE LESION | 3 0.03 13.49 BONE MARROW DISORDER | 1 0.01 13.50 BONE MARROW FAILURE | 4 0.04 13.54 BONE MARROW ISCHAEMIA | 1 0.01 13.55 BONE MARROW RETICULIN FIBROSIS | 1 0.01 13.56 BONE NEOPLASM MALIGNANT | 1 0.01 13.57 BONE PAIN | 22 0.22 13.79 BONE SCAN ABNORMAL | 1 0.01 13.80 BONE TUBERCULOSIS | 1 0.01 13.81 BORDERLINE PERSONALITY DISORDER | 1 0.01 13.82 BOWEL MOVEMENT IRREGULARITY | 1 0.01 13.83 BRADYARRHYTHMIA | 1 0.01 13.84 BRADYCARDIA | 8 0.08 13.92 BRADYKINESIA | 1 0.01 13.93 BRAIN HYPOXIA | 1 0.01 13.94 BRAIN INJURY | 3 0.03 13.97 BRAIN NATRIURETIC PEPTIDE INCREASED | 1 0.01 13.98 BRAIN NEOPLASM | 6 0.06 14.04 BRAIN OEDEMA | 3 0.03 14.07 BREAST CALCIFICATIONS | 1 0.01 14.08 BREAST CANCER | 14 0.14 14.22 BREAST CANCER FEMALE | 13 0.13 14.35 BREAST CANCER IN SITU | 2 0.02 14.37 BREAST CANCER METASTATIC | 3 0.03 14.40 BREAST CANCER RECURRENT | 1 0.01 14.41 BREAST CANCER STAGE I | 2 0.02 14.43 BREAST CANCER STAGE IV | 1 0.01 14.44 BREAST CYST | 2 0.02 14.46 BREAST ENLARGEMENT | 1 0.01 14.47 BREAST MASS | 2 0.02 14.49 BREAST PAIN | 5 0.05 14.54 BREAST TENDERNESS | 2 0.02 14.56 BREATH ODOUR | 1 0.01 14.57 BRONCHIAL FISTULA | 1 0.01 14.58 BRONCHITIS | 20 0.20 14.78 BRONCHITIS CHRONIC | 1 0.01 14.79 BRONCHOPNEUMONIA | 2 0.02 14.81 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 14.82 BRONCHOSCOPY | 1 0.01 14.83 BRONCHOSPASM | 2 0.02 14.85 BRUGADA SYNDROME | 1 0.01 14.86 BRUXISM | 1 0.01 14.87 BUNDLE BRANCH BLOCK | 1 0.01 14.88 BUNDLE BRANCH BLOCK LEFT | 4 0.04 14.92 BUNDLE BRANCH BLOCK RIGHT | 1 0.01 14.93 BURNING SENSATION | 7 0.07 15.00 BURNS SECOND DEGREE | 2 0.02 15.02 BURNS THIRD DEGREE | 1 0.01 15.03 BURSA DISORDER | 1 0.01 15.04 BURSITIS | 3 0.03 15.07 C-REACTIVE PROTEIN ABNORMAL | 1 0.01 15.08 C-REACTIVE PROTEIN INCREASED | 5 0.05 15.13 CAESAREAN SECTION | 2 0.02 15.15 CALCINOSIS | 1 0.01 15.16 CALCULUS BLADDER | 1 0.01 15.17 CALCULUS URINARY | 1 0.01 15.18 CANDIDA PNEUMONIA | 1 0.01 15.19 CANDIDA SEPSIS | 1 0.01 15.20 CANDIDIASIS | 2 0.02 15.22 CARDIAC ANEURYSM | 2 0.02 15.24 CARDIAC ARREST | 22 0.22 15.46 CARDIAC ASTHMA | 1 0.01 15.47 CARDIAC DISORDER | 19 0.19 15.66 CARDIAC ENZYMES INCREASED | 1 0.01 15.67 CARDIAC FAILURE | 19 0.19 15.86 CARDIAC FAILURE ACUTE | 1 0.01 15.87 CARDIAC FAILURE CONGESTIVE | 31 0.31 16.18 CARDIAC FIBRILLATION | 1 0.01 16.19 CARDIAC HYPERTROPHY | 1 0.01 16.20 CARDIAC MURMUR | 4 0.04 16.24 CARDIAC OPERATION | 2 0.02 16.26 CARDIAC OUTPUT DECREASED | 2 0.02 16.28 CARDIAC PACEMAKER INSERTION | 1 0.01 16.29 CARDIAC SEPTAL DEFECT | 1 0.01 16.30 CARDIAC VALVE DISEASE | 3 0.03 16.33 CARDIAC VALVE REPLACEMENT COMPLICATION | 1 0.01 16.34 CARDIAC VALVE VEGETATION | 2 0.02 16.36 CARDIO-RESPIRATORY ARREST | 9 0.09 16.45 CARDIOGENIC SHOCK | 2 0.02 16.47 CARDIOMEGALY | 10 0.10 16.57 CARDIOMYOPATHY | 5 0.05 16.62 CARDIOVASCULAR DISORDER | 16 0.16 16.78 CARNITINE DEFICIENCY | 1 0.01 16.79 CAROTID ARTERY OCCLUSION | 3 0.03 16.82 CAROTID ARTERY STENOSIS | 3 0.03 16.85 CAROTID BRUIT | 1 0.01 16.86 CARPAL TUNNEL SYNDROME | 5 0.05 16.91 CARTILAGE INJURY | 1 0.01 16.92 CARTILAGE NEOPLASM | 1 0.01 16.93 CATARACT | 10 0.10 17.03 CATARACT OPERATION | 1 0.01 17.04 CATATONIA | 2 0.02 17.06 CATHETER PLACEMENT | 1 0.01 17.07 CATHETERISATION CARDIAC | 2 0.02 17.09 CAUDA EQUINA SYNDROME | 1 0.01 17.10 CELL MARKER INCREASED | 1 0.01 17.11 CELLULITIS | 6 0.06 17.17 CELLULITIS ORBITAL | 1 0.01 17.18 CELLULITIS STAPHYLOCOCCAL | 1 0.01 17.19 CENTRAL NERVOUS SYSTEM INFECTION | 1 0.01 17.20 CENTRAL NERVOUS SYSTEM INFLAMMATION | 1 0.01 17.21 CENTRAL NERVOUS SYSTEM LESION | 6 0.06 17.27 CENTRAL NERVOUS SYSTEM LYMPHOMA | 1 0.01 17.28 CEREBELLAR HAEMORRHAGE | 1 0.01 17.29 CEREBELLAR INFARCTION | 1 0.01 17.30 CEREBRAL ARTERY EMBOLISM | 1 0.01 17.31 CEREBRAL ARTERY OCCLUSION | 1 0.01 17.32 CEREBRAL ATROPHY | 1 0.01 17.33 CEREBRAL DISORDER | 1 0.01 17.34 CEREBRAL HAEMATOMA | 2 0.02 17.36 CEREBRAL HAEMORRHAGE | 7 0.07 17.43 CEREBRAL INFARCTION | 7 0.07 17.50 CEREBRAL ISCHAEMIA | 5 0.05 17.55 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE | 1 0.01 17.56 CEREBRAL THROMBOSIS | 2 0.02 17.58 CEREBRAL VENOUS THROMBOSIS | 1 0.01 17.59 CEREBROVASCULAR ACCIDENT | 52 0.52 18.11 CEREBROVASCULAR DISORDER | 2 0.02 18.13 CEREBROVASCULAR SPASM | 1 0.01 18.14 CERUMEN IMPACTION | 2 0.02 18.16 CERVICAL DYSPLASIA | 1 0.01 18.17 CERVICAL SPINAL STENOSIS | 1 0.01 18.18 CERVICOBRACHIAL SYNDROME | 1 0.01 18.19 CHEILITIS | 1 0.01 18.20 CHEMOTHERAPEUTIC DRUG LEVEL BELOW THE.. | 1 0.01 18.21 CHEST DISCOMFORT | 12 0.12 18.33 CHEST PAIN | 48 0.48 18.81 CHILLS | 24 0.24 19.05 CHOKING | 3 0.03 19.08 CHOKING SENSATION | 1 0.01 19.09 CHOLECYSTECTOMY | 23 0.23 19.32 CHOLECYSTITIS | 19 0.19 19.51 CHOLECYSTITIS ACUTE | 5 0.05 19.56 CHOLECYSTITIS CHRONIC | 16 0.16 19.72 CHOLELITHIASIS | 31 0.31 20.03 CHOLESTASIS | 7 0.07 20.10 CHOLESTATIC LIVER INJURY | 1 0.01 20.11 CHOLESTEROSIS | 3 0.03 20.14 CHOREA | 1 0.01 20.15 CHROMATURIA | 5 0.05 20.20 CHRONIC FATIGUE SYNDROME | 1 0.01 20.21 CHRONIC GRAFT VERSUS HOST DISEASE | 5 0.05 20.26 CHRONIC MYELOID LEUKAEMIA | 1 0.01 20.27 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 1 0.01 20.28 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 13 0.13 20.41 CHRONIC SINUSITIS | 4 0.04 20.45 CIRCULATORY COLLAPSE | 7 0.07 20.52 CLAVICLE FRACTURE | 2 0.02 20.54 CLINODACTYLY | 1 0.01 20.55 CLONUS | 1 0.01 20.56 CLOSTRIDIAL INFECTION | 4 0.04 20.60 CLOSTRIDIUM BACTERAEMIA | 1 0.01 20.61 CLOSTRIDIUM DIFFICILE COLITIS | 3 0.03 20.64 CLUSTER HEADACHE | 1 0.01 20.65 COAGULATION TIME PROLONGED | 1 0.01 20.66 COAGULOPATHY | 5 0.05 20.71 COELIAC ARTERY STENOSIS | 1 0.01 20.72 COELIAC DISEASE | 1 0.01 20.73 COGAN'S SYNDROME | 1 0.01 20.74 COGNITIVE DISORDER | 14 0.14 20.88 COITAL BLEEDING | 1 0.01 20.89 COLD SWEAT | 2 0.02 20.91 COLITIS | 6 0.06 20.97 COLITIS ISCHAEMIC | 3 0.03 21.00 COLITIS ULCERATIVE | 5 0.05 21.05 COLON ADENOMA | 1 0.01 21.06 COLON CANCER | 3 0.03 21.09 COLON CANCER METASTATIC | 1 0.01 21.10 COLON NEOPLASM | 1 0.01 21.11 COLON POLYPECTOMY | 1 0.01 21.12 COLONIC POLYP | 3 0.03 21.15 COMA | 5 0.05 21.20 COMA SCALE ABNORMAL | 2 0.02 21.22 COMMUNICATION DISORDER | 1 0.01 21.23 COMPARTMENT SYNDROME | 1 0.01 21.24 COMPLEMENT FACTOR C1 DECREASED | 1 0.01 21.25 COMPLETED SUICIDE | 5 0.05 21.30 COMPLICATIONS OF TRANSPLANT SURGERY | 2 0.02 21.32 COMPRESSION FRACTURE | 4 0.04 21.36 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL | 1 0.01 21.37 CONCOMITANT DISEASE PROGRESSION | 3 0.03 21.40 CONCUSSION | 3 0.03 21.43 CONDITION AGGRAVATED | 14 0.14 21.57 CONFUSIONAL STATE | 38 0.38 21.95 CONGENITAL ANOMALY | 2 0.02 21.97 CONGENITAL BRAIN DAMAGE | 1 0.01 21.98 CONGENITAL DIAPHRAGMATIC HERNIA | 1 0.01 21.99 CONGENITAL FOOT MALFORMATION | 1 0.01 22.00 CONGENITAL HAND MALFORMATION | 1 0.01 22.01 CONGENITAL HYDRONEPHROSIS | 1 0.01 22.02 CONGENITAL MUSCULOSKELETAL ANOMALY | 1 0.01 22.03 CONGESTIVE CARDIOMYOPATHY | 1 0.01 22.04 CONJUNCTIVITIS | 4 0.04 22.08 CONNECTIVE TISSUE DISORDER | 1 0.01 22.09 CONSTIPATION | 29 0.29 22.38 CONTRAINDICATION TO MEDICAL TREATMENT | 1 0.01 22.39 CONTUSION | 15 0.15 22.54 CONVULSION | 41 0.41 22.95 CONVULSIVE THRESHOLD LOWERED | 1 0.01 22.96 COORDINATION ABNORMAL | 3 0.03 22.99 COR PULMONALE | 2 0.02 23.01 CORNEAL ABRASION | 1 0.01 23.02 CORNEAL PERFORATION | 1 0.01 23.03 CORONARY ARTERIAL STENT INSERTION | 2 0.02 23.05 CORONARY ARTERY BYPASS | 1 0.01 23.06 CORONARY ARTERY DISEASE | 23 0.23 23.29 CORONARY ARTERY EMBOLISM | 1 0.01 23.30 CORONARY ARTERY OCCLUSION | 4 0.04 23.34 CORONARY ARTERY STENOSIS | 2 0.02 23.36 CORONARY ARTERY THROMBOSIS | 1 0.01 23.37 COUGH | 23 0.23 23.60 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 23.61 CROHN'S DISEASE | 17 0.17 23.78 CRYING | 5 0.05 23.83 CRYSTAL URINE | 1 0.01 23.84 CUBITAL TUNNEL SYNDROME | 1 0.01 23.85 CUSHING'S SYNDROME | 2 0.02 23.87 CYANOSIS | 3 0.03 23.90 CYST | 2 0.02 23.92 CYSTITIS | 10 0.10 24.02 CYSTITIS NONINFECTIVE | 1 0.01 24.03 CYSTOCELE | 1 0.01 24.04 CYTOLYTIC HEPATITIS | 4 0.04 24.08 CYTOMEGALOVIRUS INFECTION | 3 0.03 24.11 CYTOMEGALOVIRUS TEST POSITIVE | 1 0.01 24.12 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 24.13 DEAFNESS | 5 0.05 24.18 DEAFNESS BILATERAL | 1 0.01 24.19 DEAFNESS NEUROSENSORY | 1 0.01 24.20 DEATH | 161 1.61 25.81 DECREASED ACTIVITY | 1 0.01 25.82 DECREASED APPETITE | 45 0.45 26.27 DECREASED EYE CONTACT | 2 0.02 26.29 DECREASED IMMUNE RESPONSIVENESS | 2 0.02 26.31 DECREASED INTEREST | 3 0.03 26.34 DECUBITUS ULCER | 4 0.04 26.38 DEEP VEIN THROMBOSIS | 33 0.33 26.71 DEFAECATION URGENCY | 1 0.01 26.72 DEFORMITY | 4 0.04 26.76 DEHYDRATION | 21 0.21 26.97 DELAYED RECOVERY FROM ANAESTHESIA | 1 0.01 26.98 DELIRIUM | 6 0.06 27.04 DELUSION | 6 0.06 27.10 DEMENTIA | 7 0.07 27.17 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 27.18 DEMYELINATION | 1 0.01 27.19 DENGUE FEVER | 2 0.02 27.21 DENTAL CARIES | 10 0.10 27.31 DENTAL FISTULA | 1 0.01 27.32 DENTAL IMPLANTATION | 1 0.01 27.33 DENTAL NECROSIS | 1 0.01 27.34 DENTAL OPERATION | 1 0.01 27.35 DENTURE WEARER | 1 0.01 27.36 DEPENDENCE | 2 0.02 27.38 DEPRESSED LEVEL OF CONSCIOUSNESS | 6 0.06 27.44 DEPRESSED MOOD | 5 0.05 27.49 DEPRESSION | 58 0.58 28.07 DEPRESSIVE SYMPTOM | 1 0.01 28.08 DERMAL CYST | 1 0.01 28.09 DERMATITIS | 4 0.04 28.13 DERMATITIS ACNEIFORM | 1 0.01 28.14 DERMATITIS ATOPIC | 1 0.01 28.15 DERMATITIS BULLOUS | 1 0.01 28.16 DERMATITIS CONTACT | 2 0.02 28.18 DERMATOMYOSITIS | 1 0.01 28.19 DEVELOPMENTAL DELAY | 5 0.05 28.24 DEVICE BREAKAGE | 2 0.02 28.26 DEVICE DISLOCATION | 5 0.05 28.31 DEVICE EXPULSION | 28 0.28 28.59 DEVICE FAILURE | 1 0.01 28.60 DEVICE ISSUE | 2 0.02 28.62 DEVICE LEAKAGE | 1 0.01 28.63 DEVICE MALFUNCTION | 6 0.06 28.69 DEVICE OCCLUSION | 1 0.01 28.70 DEVICE RELATED INFECTION | 6 0.06 28.76 DEVICE RELATED SEPSIS | 1 0.01 28.77 DIABETES MELLITUS | 10 0.10 28.87 DIABETES MELLITUS INADEQUATE CONTROL | 2 0.02 28.89 DIABETIC COMA | 2 0.02 28.91 DIABETIC KETOACIDOSIS | 3 0.03 28.94 DIABETIC MICROANGIOPATHY | 1 0.01 28.95 DIABETIC NEUROPATHY | 1 0.01 28.96 DIABETIC RETINOPATHY | 2 0.02 28.98 DIALYSIS | 1 0.01 28.99 DIARRHOEA | 72 0.72 29.71 DIARRHOEA HAEMORRHAGIC | 1 0.01 29.72 DIASTOLIC DYSFUNCTION | 1 0.01 29.73 DIFFUSE LARGE B-CELL LYMPHOMA | 1 0.01 29.74 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT | 1 0.01 29.75 DILATATION VENTRICULAR | 2 0.02 29.77 DIPLEGIA | 2 0.02 29.79 DIPLOPIA | 3 0.03 29.82 DISABILITY | 3 0.03 29.85 DISCOMFORT | 5 0.05 29.90 DISEASE PROGRESSION | 9 0.09 29.99 DISEASE RECURRENCE | 1 0.01 30.00 DISINHIBITION | 1 0.01 30.01 DISORIENTATION | 11 0.11 30.12 DISSEMINATED INTRAVASCULAR COAGULATION | 5 0.05 30.17 DISSOCIATION | 1 0.01 30.18 DISTURBANCE IN ATTENTION | 7 0.07 30.25 DISTURBANCE IN SOCIAL BEHAVIOUR | 2 0.02 30.27 DIVERTICULITIS | 1 0.01 30.28 DIVERTICULUM | 4 0.04 30.32 DIVERTICULUM INTESTINAL | 4 0.04 30.36 DIVERTICULUM INTESTINAL HAEMORRHAGIC | 3 0.03 30.39 DIZZINESS | 72 0.72 31.11 DIZZINESS POSTURAL | 1 0.01 31.12 DNA ANTIBODY POSITIVE | 1 0.01 31.13 DRUG ABUSE | 1 0.01 31.14 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 1 0.01 31.15 DRUG ADMINISTRATION ERROR | 5 0.05 31.20 DRUG DELIVERY DEVICE IMPLANTATION | 1 0.01 31.21 DRUG DEPENDENCE | 3 0.03 31.24 DRUG DISPENSING ERROR | 4 0.04 31.28 DRUG DOSE OMISSION | 14 0.14 31.42 DRUG EFFECT DECREASED | 9 0.09 31.51 DRUG EFFECT DELAYED | 1 0.01 31.52 DRUG EFFECT INCREASED | 1 0.01 31.53 DRUG ERUPTION | 3 0.03 31.56 DRUG EXPOSURE BEFORE PREGNANCY | 1 0.01 31.57 DRUG EXPOSURE DURING PREGNANCY | 23 0.23 31.80 DRUG EXPOSURE VIA BREAST MILK | 2 0.02 31.82 DRUG HYPERSENSITIVITY | 12 0.12 31.94 DRUG INEFFECTIVE | 56 0.56 32.50 DRUG INTERACTION | 25 0.25 32.75 DRUG INTOLERANCE | 3 0.03 32.78 DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 32.79 DRUG PRESCRIBING ERROR | 4 0.04 32.83 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 5 0.05 32.88 DRUG RESISTANCE | 1 0.01 32.89 DRUG SPECIFIC ANTIBODY PRESENT | 1 0.01 32.90 DRUG TOLERANCE | 2 0.02 32.92 DRUG WITHDRAWAL SYNDROME | 6 0.06 32.98 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 32.99 DRY EYE | 1 0.01 33.00 DRY MOUTH | 13 0.13 33.13 DRY SKIN | 8 0.08 33.21 DRY THROAT | 1 0.01 33.22 DUODENAL ATRESIA | 1 0.01 33.23 DUODENAL STENOSIS | 1 0.01 33.24 DUODENAL ULCER | 5 0.05 33.29 DUODENAL ULCER HAEMORRHAGE | 2 0.02 33.31 DUODENAL ULCER PERFORATION | 1 0.01 33.32 DUODENAL ULCER REPAIR | 1 0.01 33.33 DYSARTHRIA | 6 0.06 33.39 DYSGEUSIA | 6 0.06 33.45 DYSGRAPHIA | 1 0.01 33.46 DYSKINESIA | 9 0.09 33.55 DYSLIPIDAEMIA | 2 0.02 33.57 DYSMENORRHOEA | 1 0.01 33.58 DYSMORPHISM | 1 0.01 33.59 DYSPEPSIA | 17 0.17 33.76 DYSPHAGIA | 16 0.16 33.92 DYSPHONIA | 4 0.04 33.96 DYSPHORIA | 1 0.01 33.97 DYSPNOEA | 90 0.90 34.87 DYSPNOEA AT REST | 1 0.01 34.88 DYSPNOEA EXERTIONAL | 3 0.03 34.91 DYSSTASIA | 7 0.07 34.98 DYSTONIA | 4 0.04 35.02 DYSURIA | 6 0.06 35.08 EAR DISCOMFORT | 1 0.01 35.09 EAR DISORDER | 1 0.01 35.10 EAR INFECTION | 3 0.03 35.13 EAR PAIN | 2 0.02 35.15 EAR PRURITUS | 2 0.02 35.17 EATING DISORDER | 3 0.03 35.20 ECCHYMOSIS | 4 0.04 35.24 ECHOCARDIOGRAM | 1 0.01 35.25 ECTOPIC PREGNANCY | 3 0.03 35.28 ECZEMA | 3 0.03 35.31 ECZEMA INFECTED | 1 0.01 35.32 EDENTULOUS | 2 0.02 35.34 EJECTION FRACTION DECREASED | 2 0.02 35.36 ELECTROCARDIOGRAM | 1 0.01 35.37 ELECTROCARDIOGRAM ABNORMAL | 1 0.01 35.38 ELECTROCARDIOGRAM Q WAVE ABNORMAL | 1 0.01 35.39 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 35.40 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED | 1 0.01 35.41 ELECTROCARDIOGRAM QT PROLONGED | 6 0.06 35.47 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 2 0.02 35.49 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 35.50 ELECTROCARDIOGRAM T WAVE ABNORMAL | 1 0.01 35.51 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 35.52 ELECTROLYTE IMBALANCE | 1 0.01 35.53 EMBOLISM ARTERIAL | 1 0.01 35.54 EMOTIONAL DISORDER | 4 0.04 35.58 EMOTIONAL DISTRESS | 51 0.51 36.09 EMPHYSEMA | 2 0.02 36.11 ENCEPHALITIS | 2 0.02 36.13 ENCEPHALOPATHY | 12 0.12 36.25 ENDOCARDITIS | 2 0.02 36.27 ENDOMETRIAL HYPERTROPHY | 1 0.01 36.28 ENDOMETRIOSIS | 1 0.01 36.29 ENGRAFT FAILURE | 2 0.02 36.31 ENTEROCOCCAL INFECTION | 1 0.01 36.32 ENTEROCOCCUS TEST POSITIVE | 1 0.01 36.33 ENTEROCOLITIS | 1 0.01 36.34 ENURESIS | 2 0.02 36.36 EOSINOPHIL COUNT INCREASED | 1 0.01 36.37 EOSINOPHILIA | 2 0.02 36.39 EPICONDYLITIS | 3 0.03 36.42 EPIDURAL LIPOMATOSIS | 1 0.01 36.43 EPILEPSY | 6 0.06 36.49 EPISTAXIS | 10 0.10 36.59 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 36.61 EPULIS | 1 0.01 36.62 ERECTILE DYSFUNCTION | 4 0.04 36.66 EROSIVE DUODENITIS | 3 0.03 36.69 EROSIVE OESOPHAGITIS | 5 0.05 36.74 ERUCTATION | 3 0.03 36.77 ERYTHEMA | 33 0.33 37.10 ERYTHEMA INFECTIOSUM | 2 0.02 37.12 ERYTHEMA MULTIFORME | 1 0.01 37.13 ERYTHEMA NODOSUM | 2 0.02 37.15 ESCHERICHIA BACTERAEMIA | 1 0.01 37.16 ESCHERICHIA INFECTION | 1 0.01 37.17 ESCHERICHIA SEPSIS | 1 0.01 37.18 ESCHERICHIA TEST POSITIVE | 1 0.01 37.19 ESCHERICHIA URINARY TRACT INFECTION | 2 0.02 37.21 ESSENTIAL HYPERTENSION | 1 0.01 37.22 EUPHORIC MOOD | 5 0.05 37.27 EXCESSIVE GRANULATION TISSUE | 1 0.01 37.28 EXCORIATION | 2 0.02 37.30 EXERCISE TOLERANCE DECREASED | 2 0.02 37.32 EXOMPHALOS | 1 0.01 37.33 EXOSTOSIS | 3 0.03 37.36 EXPOSURE TO CONTAMINATED DEVICE | 1 0.01 37.37 EXTRAPYRAMIDAL DISORDER | 3 0.03 37.40 EXTRASYSTOLES | 1 0.01 37.41 EXTREMITY NECROSIS | 1 0.01 37.42 EYE ALLERGY | 1 0.01 37.43 EYE DEGENERATIVE DISORDER | 1 0.01 37.44 EYE DISORDER | 5 0.05 37.49 EYE EXCISION | 1 0.01 37.50 EYE HAEMORRHAGE | 2 0.02 37.52 EYE INFECTION | 2 0.02 37.54 EYE INFLAMMATION | 1 0.01 37.55 EYE IRRITATION | 2 0.02 37.57 EYE OEDEMA | 1 0.01 37.58 EYE OPERATION | 1 0.01 37.59 EYE PAIN | 4 0.04 37.63 EYE SWELLING | 3 0.03 37.66 EYELID BLEEDING | 1 0.01 37.67 EYELID OEDEMA | 3 0.03 37.70 EYELIDS PRURITUS | 1 0.01 37.71 FACE INJURY | 2 0.02 37.73 FACE OEDEMA | 4 0.04 37.77 FACET JOINT SYNDROME | 3 0.03 37.80 FACIAL BONES FRACTURE | 1 0.01 37.81 FACIAL PAIN | 4 0.04 37.85 FACIAL PARESIS | 1 0.01 37.86 FACTOR V LEIDEN MUTATION | 1 0.01 37.87 FAECAL INCONTINENCE | 8 0.08 37.95 FAECALOMA | 2 0.02 37.97 FAECES DISCOLOURED | 7 0.07 38.04 FAECES HARD | 2 0.02 38.06 FAILURE TO THRIVE | 1 0.01 38.07 FALL | 89 0.89 38.96 FANCONI SYNDROME ACQUIRED | 1 0.01 38.97 FATIGUE | 80 0.80 39.77 FEAR | 22 0.22 39.99 FEAR OF DEATH | 1 0.01 40.00 FEBRILE BONE MARROW APLASIA | 1 0.01 40.01 FEBRILE NEUTROPENIA | 11 0.11 40.12 FEEDING DISORDER NEONATAL | 1 0.01 40.13 FEELING ABNORMAL | 33 0.33 40.46 FEELING COLD | 7 0.07 40.53 FEELING HOT | 6 0.06 40.59 FEELING JITTERY | 2 0.02 40.61 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 40.62 FEELING OF DESPAIR | 2 0.02 40.64 FEMORAL ARTERIAL STENOSIS | 1 0.01 40.65 FEMORAL HERNIA | 1 0.01 40.66 FEMORAL NECK FRACTURE | 4 0.04 40.70 FEMUR FRACTURE | 16 0.16 40.86 FIBROCYSTIC BREAST DISEASE | 1 0.01 40.87 FIBROMYALGIA | 3 0.03 40.90 FIBROSIS | 3 0.03 40.93 FIBULA FRACTURE | 2 0.02 40.95 FINGER AMPUTATION | 1 0.01 40.96 FINGER DEFORMITY | 1 0.01 40.97 FINGER HYPOPLASIA | 1 0.01 40.98 FISTULA | 4 0.04 41.02 FISTULA DISCHARGE | 1 0.01 41.03 FISTULA REPAIR | 1 0.01 41.04 FLANK PAIN | 1 0.01 41.05 FLATULENCE | 9 0.09 41.14 FLUID OVERLOAD | 2 0.02 41.16 FLUID RETENTION | 7 0.07 41.23 FLUSHING | 9 0.09 41.32 FOAMING AT MOUTH | 2 0.02 41.34 FOETAL DISTRESS SYNDROME | 1 0.01 41.35 FOETAL MALFORMATION | 1 0.01 41.36 FOLLICULITIS | 2 0.02 41.38 FOOD ALLERGY | 1 0.01 41.39 FOOD INTOLERANCE | 2 0.02 41.41 FOOD POISONING | 1 0.01 41.42 FOOT DEFORMITY | 1 0.01 41.43 FOOT FRACTURE | 3 0.03 41.46 FOREIGN BODY IN EYE | 1 0.01 41.47 FRACTURE | 3 0.03 41.50 FRACTURE DELAYED UNION | 2 0.02 41.52 FRACTURE NONUNION | 2 0.02 41.54 FRACTURE OF PENIS | 1 0.01 41.55 FRACTURED COCCYX | 1 0.01 41.56 FREEZING PHENOMENON | 1 0.01 41.57 FREQUENT BOWEL MOVEMENTS | 3 0.03 41.60 FRUSTRATION | 2 0.02 41.62 FULL BLOOD COUNT DECREASED | 1 0.01 41.63 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM | 1 0.01 41.64 FUNGAL INFECTION | 7 0.07 41.71 FUNGAL OESOPHAGITIS | 1 0.01 41.72 FUNGAL PERITONITIS | 2 0.02 41.74 FUNGAL SKIN INFECTION | 1 0.01 41.75 GAIT DISTURBANCE | 46 0.46 42.21 GALACTORRHOEA | 1 0.01 42.22 GALLBLADDER CHOLESTEROLOSIS | 5 0.05 42.27 GALLBLADDER DISORDER | 17 0.17 42.44 GALLBLADDER INJURY | 10 0.10 42.54 GALLBLADDER NECROSIS | 1 0.01 42.55 GALLBLADDER NON-FUNCTIONING | 2 0.02 42.57 GALLBLADDER OPERATION | 2 0.02 42.59 GALLBLADDER PAIN | 1 0.01 42.60 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL | 1 0.01 42.61 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 8 0.08 42.69 GANGRENE | 2 0.02 42.71 GASTRIC CANCER | 1 0.01 42.72 GASTRIC DISORDER | 7 0.07 42.79 GASTRIC FISTULA | 1 0.01 42.80 GASTRIC HAEMORRHAGE | 1 0.01 42.81 GASTRIC POLYPS | 3 0.03 42.84 GASTRIC ULCER | 7 0.07 42.91 GASTRIC ULCER HAEMORRHAGE | 2 0.02 42.93 GASTRITIS | 14 0.14 43.07 GASTRITIS ATROPHIC | 1 0.01 43.08 GASTRITIS FUNGAL | 1 0.01 43.09 GASTROENTERITIS | 6 0.06 43.15 GASTROENTERITIS CLOSTRIDIAL | 2 0.02 43.17 GASTROENTERITIS VIRAL | 1 0.01 43.18 GASTROINTESTINAL DISORDER | 6 0.06 43.24 GASTROINTESTINAL HAEMORRHAGE | 22 0.22 43.46 GASTROINTESTINAL HYPOMOTILITY | 1 0.01 43.47 GASTROINTESTINAL INFECTION | 3 0.03 43.50 GASTROINTESTINAL INJURY | 1 0.01 43.51 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 43.52 GASTROINTESTINAL NECROSIS | 1 0.01 43.53 GASTROINTESTINAL PAIN | 3 0.03 43.56 GASTROINTESTINAL PERFORATION | 1 0.01 43.57 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 43.58 GASTROINTESTINAL TOXICITY | 1 0.01 43.59 GASTROINTESTINAL TRACT ADENOMA | 1 0.01 43.60 GASTROOESOPHAGEAL REFLUX DISEASE | 22 0.22 43.82 GASTROSCHISIS | 1 0.01 43.83 GASTROSTOMY TUBE INSERTION | 1 0.01 43.84 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 43.85 GENERAL PHYSICAL HEALTH DETERIORATION | 39 0.39 44.24 GENERAL SYMPTOM | 3 0.03 44.27 GENERALISED ANXIETY DISORDER | 2 0.02 44.29 GENERALISED ERYTHEMA | 4 0.04 44.33 GENERALISED OEDEMA | 2 0.02 44.35 GENITAL ABSCESS | 1 0.01 44.36 GENITAL HAEMORRHAGE | 1 0.01 44.37 GENITOURINARY TRACT NEOPLASM | 1 0.01 44.38 GENOTYPE DRUG RESISTANCE TEST POSITIVE | 1 0.01 44.39 GINGIVAL BLEEDING | 4 0.04 44.43 GINGIVAL DISORDER | 1 0.01 44.44 GINGIVAL ERYTHEMA | 2 0.02 44.46 GINGIVAL HYPERTROPHY | 1 0.01 44.47 GINGIVAL INFECTION | 2 0.02 44.49 GINGIVAL PAIN | 3 0.03 44.52 GINGIVAL RECESSION | 1 0.01 44.53 GINGIVAL SWELLING | 3 0.03 44.56 GINGIVAL ULCERATION | 2 0.02 44.58 GINGIVITIS | 2 0.02 44.60 GLAUCOMA | 3 0.03 44.63 GLAUCOMATOCYCLITIC CRISES | 1 0.01 44.64 GLOMERULAR FILTRATION RATE | 1 0.01 44.65 GLOMERULAR FILTRATION RATE DECREASED | 1 0.01 44.66 GLOMERULONEPHRITIS | 1 0.01 44.67 GLOSSODYNIA | 3 0.03 44.70 GLUCOSE URINE | 1 0.01 44.71 GLYCOSYLATED HAEMOGLOBIN INCREASED | 5 0.05 44.76 GOITRE | 3 0.03 44.79 GOUT | 4 0.04 44.83 GRAFT INFECTION | 1 0.01 44.84 GRAFT VERSUS HOST DISEASE | 3 0.03 44.87 GRAFT VERSUS HOST DISEASE IN LUNG | 1 0.01 44.88 GRAND MAL CONVULSION | 8 0.08 44.96 GRANULOCYTOPENIA | 1 0.01 44.97 GRANULOMA | 1 0.01 44.98 GRANULOMA ANNULARE | 1 0.01 44.99 GRANULOMATOUS LIVER DISEASE | 1 0.01 45.00 GRIP STRENGTH | 1 0.01 45.01 GROIN PAIN | 1 0.01 45.02 GROWTH RETARDATION | 1 0.01 45.03 GUILLAIN-BARRE SYNDROME | 3 0.03 45.06 GYNAECOMASTIA | 3 0.03 45.09 H1N1 INFLUENZA | 2 0.02 45.11 HAEMANGIOMA OF LIVER | 3 0.03 45.14 HAEMATEMESIS | 8 0.08 45.22 HAEMATOCHEZIA | 10 0.10 45.32 HAEMATOCRIT DECREASED | 5 0.05 45.37 HAEMATOLOGICAL MALIGNANCY | 1 0.01 45.38 HAEMATOLOGY TEST ABNORMAL | 1 0.01 45.39 HAEMATOMA | 7 0.07 45.46 HAEMATOMA EVACUATION | 1 0.01 45.47 HAEMATOTOXICITY | 2 0.02 45.49 HAEMATURIA | 4 0.04 45.53 HAEMOCHROMATOSIS | 1 0.01 45.54 HAEMODIALYSIS | 2 0.02 45.56 HAEMOGLOBIN | 1 0.01 45.57 HAEMOGLOBIN ABNORMAL | 1 0.01 45.58 HAEMOGLOBIN DECREASED | 17 0.17 45.75 HAEMOGLOBINURIA | 1 0.01 45.76 HAEMOLYSIS | 1 0.01 45.77 HAEMOLYTIC ANAEMIA | 1 0.01 45.78 HAEMOPHILUS BACTERAEMIA | 1 0.01 45.79 HAEMOPHILUS INFECTION | 1 0.01 45.80 HAEMOPTYSIS | 8 0.08 45.88 HAEMORRHAGE | 16 0.16 46.04 HAEMORRHAGE INTRACRANIAL | 2 0.02 46.06 HAEMORRHAGIC ANAEMIA | 3 0.03 46.09 HAEMORRHAGIC CEREBRAL INFARCTION | 1 0.01 46.10 HAEMORRHAGIC DIATHESIS | 2 0.02 46.12 HAEMORRHAGIC INFARCTION | 1 0.01 46.13 HAEMORRHAGIC OVARIAN CYST | 1 0.01 46.14 HAEMORRHAGIC STROKE | 1 0.01 46.15 HAEMORRHOIDS | 6 0.06 46.21 HAEMOTHORAX | 1 0.01 46.22 HAIR TEXTURE ABNORMAL | 1 0.01 46.23 HALLUCINATION | 15 0.15 46.38 HALLUCINATION, AUDITORY | 5 0.05 46.43 HALLUCINATION, VISUAL | 2 0.02 46.45 HAND FRACTURE | 3 0.03 46.48 HEAD DISCOMFORT | 1 0.01 46.49 HEAD INJURY | 12 0.12 46.61 HEADACHE | 71 0.71 47.32 HEART DISEASE CONGENITAL | 1 0.01 47.33 HEART INJURY | 1 0.01 47.34 HEART RATE DECREASED | 4 0.04 47.38 HEART RATE INCREASED | 20 0.20 47.58 HEART RATE IRREGULAR | 1 0.01 47.59 HEART VALVE INCOMPETENCE | 1 0.01 47.60 HEART VALVE REPLACEMENT | 2 0.02 47.62 HELICOBACTER GASTRITIS | 1 0.01 47.63 HEMIPARESIS | 5 0.05 47.68 HEMIPLEGIA | 3 0.03 47.71 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 47.72 HEPATIC CIRRHOSIS | 7 0.07 47.79 HEPATIC ENCEPHALOPATHY | 4 0.04 47.83 HEPATIC ENZYME INCREASED | 7 0.07 47.90 HEPATIC FAILURE | 9 0.09 47.99 HEPATIC FUNCTION ABNORMAL | 13 0.13 48.12 HEPATIC LESION | 1 0.01 48.13 HEPATIC NECROSIS | 1 0.01 48.14 HEPATIC NEOPLASM | 3 0.03 48.17 HEPATIC NEOPLASM MALIGNANT | 6 0.06 48.23 HEPATIC STEATOSIS | 5 0.05 48.28 HEPATITIS | 1 0.01 48.29 HEPATITIS ACUTE | 1 0.01 48.30 HEPATITIS ALCOHOLIC | 1 0.01 48.31 HEPATITIS B | 3 0.03 48.34 HEPATITIS CHOLESTATIC | 3 0.03 48.37 HEPATITIS FULMINANT | 1 0.01 48.38 HEPATITIS TOXIC | 1 0.01 48.39 HEPATOCELLULAR INJURY | 2 0.02 48.41 HEPATOMEGALY | 5 0.05 48.46 HEPATORENAL SYNDROME | 2 0.02 48.48 HEPATOSPLENOMEGALY | 1 0.01 48.49 HEPATOTOXICITY | 8 0.08 48.57 HERNIA PAIN | 1 0.01 48.58 HERNIA REPAIR | 1 0.01 48.59 HERPES SIMPLEX | 1 0.01 48.60 HERPES VIRUS INFECTION | 1 0.01 48.61 HERPES ZOSTER | 9 0.09 48.70 HIATUS HERNIA | 6 0.06 48.76 HICCUPS | 1 0.01 48.77 HILAR LYMPHADENOPATHY | 1 0.01 48.78 HIP ARTHROPLASTY | 4 0.04 48.82 HIP FRACTURE | 15 0.15 48.97 HIP SURGERY | 1 0.01 48.98 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 49.00 HIV INFECTION | 1 0.01 49.01 HODGKIN'S DISEASE | 3 0.03 49.04 HOLT-ORAM SYNDROME | 1 0.01 49.05 HOSPICE CARE | 1 0.01 49.06 HOSPITALISATION | 8 0.08 49.14 HOSTILITY | 1 0.01 49.15 HOT FLUSH | 13 0.13 49.28 HUMERUS FRACTURE | 5 0.05 49.33 HUNGER | 1 0.01 49.34 HYDROCELE | 2 0.02 49.36 HYDROCELE OPERATION | 1 0.01 49.37 HYDROCEPHALUS | 3 0.03 49.40 HYPERAEMIA | 2 0.02 49.42 HYPERAESTHESIA | 1 0.01 49.43 HYPERAMMONAEMIA | 1 0.01 49.44 HYPERCALCAEMIA | 2 0.02 49.46 HYPERCAPNIA | 1 0.01 49.47 HYPERCHOLESTEROLAEMIA | 4 0.04 49.51 HYPERCOAGULATION | 1 0.01 49.52 HYPERGAMMAGLOBULINAEMIA | 1 0.01 49.53 HYPERGLYCAEMIA | 8 0.08 49.61 HYPERHIDROSIS | 8 0.08 49.69 HYPERKALAEMIA | 7 0.07 49.76 HYPERLIPIDAEMIA | 8 0.08 49.84 HYPERNATRAEMIA | 1 0.01 49.85 HYPEROSMOLAR STATE | 1 0.01 49.86 HYPERPHOSPHATASAEMIA | 1 0.01 49.87 HYPERSENSITIVITY | 24 0.24 50.11 HYPERSOMNIA | 3 0.03 50.14 HYPERTENSION | 36 0.36 50.50 HYPERTENSIVE CRISIS | 4 0.04 50.54 HYPERTENSIVE EMERGENCY | 1 0.01 50.55 HYPERTENSIVE HEART DISEASE | 1 0.01 50.56 HYPERTHERMIA | 1 0.01 50.57 HYPERTHYROIDISM | 5 0.05 50.62 HYPERTONIA | 1 0.01 50.63 HYPERTONIC BLADDER | 2 0.02 50.65 HYPERTRIGLYCERIDAEMIA | 1 0.01 50.66 HYPERVENTILATION | 1 0.01 50.67 HYPERVIGILANCE | 1 0.01 50.68 HYPOACUSIS | 2 0.02 50.70 HYPOAESTHESIA | 25 0.25 50.95 HYPOAESTHESIA FACIAL | 2 0.02 50.97 HYPOAESTHESIA ORAL | 2 0.02 50.99 HYPOALBUMINAEMIA | 2 0.02 51.01 HYPOCALCAEMIA | 9 0.09 51.10 HYPOGAMMAGLOBULINAEMIA | 2 0.02 51.12 HYPOGLYCAEMIA | 7 0.07 51.19 HYPOGLYCAEMIA NEONATAL | 1 0.01 51.20 HYPOGLYCAEMIC UNCONSCIOUSNESS | 2 0.02 51.22 HYPOKALAEMIA | 14 0.14 51.36 HYPOMAGNESAEMIA | 4 0.04 51.40 HYPOMENORRHOEA | 1 0.01 51.41 HYPONATRAEMIA | 11 0.11 51.52 HYPOPHAGIA | 6 0.06 51.58 HYPOPHOSPHATAEMIA | 3 0.03 51.61 HYPOPROTEINAEMIA | 1 0.01 51.62 HYPOTENSION | 31 0.31 51.93 HYPOTHERMIA | 3 0.03 51.96 HYPOTHYROIDISM | 12 0.12 52.08 HYPOTONIA | 4 0.04 52.12 HYPOVOLAEMIC SHOCK | 1 0.01 52.13 HYPOXIA | 6 0.06 52.19 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY | 3 0.03 52.22 ICHTHYOSIS | 1 0.01 52.23 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 52.24 ILEAL STENOSIS | 1 0.01 52.25 ILEITIS | 3 0.03 52.28 ILEUS | 3 0.03 52.31 ILEUS PARALYTIC | 2 0.02 52.33 ILL-DEFINED DISORDER | 5 0.05 52.38 IMMOBILE | 3 0.03 52.41 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 52.42 IMMUNE SYSTEM DISORDER | 1 0.01 52.43 IMMUNODEFICIENCY | 2 0.02 52.45 IMPAIRED DRIVING ABILITY | 1 0.01 52.46 IMPAIRED HEALING | 8 0.08 52.54 IMPAIRED SELF-CARE | 1 0.01 52.55 IMPAIRED WORK ABILITY | 1 0.01 52.56 IMPATIENCE | 1 0.01 52.57 IMPETIGO | 1 0.01 52.58 IMPULSE-CONTROL DISORDER | 1 0.01 52.59 IMPULSIVE BEHAVIOUR | 1 0.01 52.60 IN-STENT CORONARY ARTERY RESTENOSIS | 1 0.01 52.61 INADEQUATE ANALGESIA | 2 0.02 52.63 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 3 0.03 52.66 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 7 0.07 52.73 INCONTINENCE | 1 0.01 52.74 INCORRECT DOSE ADMINISTERED | 7 0.07 52.81 INCORRECT DRUG ADMINISTRATION DURATION | 5 0.05 52.86 INCORRECT ROUTE OF DRUG ADMINISTRATION | 3 0.03 52.89 INCREASED UPPER AIRWAY SECRETION | 1 0.01 52.90 INFARCTION | 5 0.05 52.95 INFECTED CYST | 1 0.01 52.96 INFECTION | 24 0.24 53.20 INFECTION SUSCEPTIBILITY INCREASED | 1 0.01 53.21 INFLAMMATION | 12 0.12 53.33 INFLAMMATORY BOWEL DISEASE | 7 0.07 53.40 INFLAMMATORY MARKER INCREASED | 1 0.01 53.41 INFLUENZA | 16 0.16 53.57 INFLUENZA A VIRUS TEST POSITIVE | 1 0.01 53.58 INFLUENZA LIKE ILLNESS | 16 0.16 53.74 INFREQUENT BOWEL MOVEMENTS | 1 0.01 53.75 INFUSION RELATED REACTION | 7 0.07 53.82 INFUSION SITE EXTRAVASATION | 1 0.01 53.83 INFUSION SITE REACTION | 1 0.01 53.84 INGUINAL HERNIA | 1 0.01 53.85 INITIAL INSOMNIA | 2 0.02 53.87 INJECTION SITE CELLULITIS | 1 0.01 53.88 INJECTION SITE DISCOLOURATION | 1 0.01 53.89 INJECTION SITE ERYTHEMA | 17 0.17 54.06 INJECTION SITE EXTRAVASATION | 1 0.01 54.07 INJECTION SITE HAEMATOMA | 9 0.09 54.16 INJECTION SITE HAEMORRHAGE | 3 0.03 54.19 INJECTION SITE INDURATION | 3 0.03 54.22 INJECTION SITE INFECTION | 2 0.02 54.24 INJECTION SITE IRRITATION | 2 0.02 54.26 INJECTION SITE NODULE | 3 0.03 54.29 INJECTION SITE OEDEMA | 1 0.01 54.30 INJECTION SITE PAIN | 12 0.12 54.42 INJECTION SITE PAPULE | 1 0.01 54.43 INJECTION SITE PRURITUS | 4 0.04 54.47 INJECTION SITE REACTION | 5 0.05 54.52 INJECTION SITE SCAR | 2 0.02 54.54 INJECTION SITE SWELLING | 3 0.03 54.57 INJECTION SITE VESICLES | 2 0.02 54.59 INJECTION SITE WARMTH | 1 0.01 54.60 INJURY | 72 0.72 55.32 INJURY ASSOCIATED WITH DEVICE | 1 0.01 55.33 INSOMNIA | 39 0.39 55.72 INTENTIONAL DRUG MISUSE | 5 0.05 55.77 INTENTIONAL OVERDOSE | 7 0.07 55.84 INTENTIONAL SELF-INJURY | 1 0.01 55.85 INTERNATIONAL NORMALISED RATIO ABNORMAL | 2 0.02 55.87 INTERNATIONAL NORMALISED RATIO INCREA.. | 6 0.06 55.93 INTERSTITIAL LUNG DISEASE | 14 0.14 56.07 INTERVERTEBRAL DISC DEGENERATION | 6 0.06 56.13 INTERVERTEBRAL DISC DISORDER | 2 0.02 56.15 INTERVERTEBRAL DISC PROTRUSION | 10 0.10 56.25 INTESTINAL HAEMORRHAGE | 1 0.01 56.26 INTESTINAL INFARCTION | 1 0.01 56.27 INTESTINAL OBSTRUCTION | 6 0.06 56.33 INTESTINAL PERFORATION | 4 0.04 56.37 INTESTINAL ULCER | 1 0.01 56.38 INTRA-UTERINE DEATH | 1 0.01 56.39 INTRACARDIAC THROMBUS | 1 0.01 56.40 INTRACRANIAL ANEURYSM | 2 0.02 56.42 INTRACRANIAL PRESSURE INCREASED | 1 0.01 56.43 INTRAVENTRICULAR HAEMORRHAGE | 1 0.01 56.44 IRON DEFICIENCY | 1 0.01 56.45 IRON DEFICIENCY ANAEMIA | 2 0.02 56.47 IRRITABILITY | 7 0.07 56.54 IRRITABLE BOWEL SYNDROME | 3 0.03 56.57 ISCHAEMIA | 2 0.02 56.59 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 56.60 ISCHAEMIC CEREBRAL INFARCTION | 1 0.01 56.61 ISCHAEMIC STROKE | 1 0.01 56.62 ITCHING SCAR | 1 0.01 56.63 JAUNDICE | 7 0.07 56.70 JAUNDICE CHOLESTATIC | 1 0.01 56.71 JAUNDICE NEONATAL | 2 0.02 56.73 JAW DISORDER | 5 0.05 56.78 JAW FRACTURE | 1 0.01 56.79 JOINT CREPITATION | 2 0.02 56.81 JOINT DISLOCATION | 2 0.02 56.83 JOINT EFFUSION | 2 0.02 56.85 JOINT INJURY | 7 0.07 56.92 JOINT LOCK | 2 0.02 56.94 JOINT RANGE OF MOTION DECREASED | 2 0.02 56.96 JOINT SPRAIN | 1 0.01 56.97 JOINT STIFFNESS | 5 0.05 57.02 JOINT SWELLING | 13 0.13 57.15 JUGULAR VEIN THROMBOSIS | 1 0.01 57.16 KERATITIS | 1 0.01 57.17 KETOACIDOSIS | 1 0.01 57.18 KIDNEY INFECTION | 4 0.04 57.22 KLEBSIELLA INFECTION | 2 0.02 57.24 KNEE ARTHROPLASTY | 4 0.04 57.28 KNEE OPERATION | 2 0.02 57.30 KYPHOSIS | 1 0.01 57.31 LABILE BLOOD PRESSURE | 1 0.01 57.32 LABORATORY TEST ABNORMAL | 2 0.02 57.34 LABYRINTHITIS | 1 0.01 57.35 LACERATION | 8 0.08 57.43 LACRIMAL DISORDER | 1 0.01 57.44 LACTATION DISORDER | 1 0.01 57.45 LACTIC ACIDOSIS | 2 0.02 57.47 LACTOSE INTOLERANCE | 1 0.01 57.48 LACUNAR INFARCTION | 3 0.03 57.51 LARGE INTESTINAL ULCER | 1 0.01 57.52 LARGE INTESTINAL ULCER HAEMORRHAGE | 4 0.04 57.56 LARGE INTESTINE CARCINOMA | 1 0.01 57.57 LARGE INTESTINE PERFORATION | 2 0.02 57.59 LARYNGEAL DISORDER | 1 0.01 57.60 LARYNGEAL OEDEMA | 2 0.02 57.62 LARYNGITIS | 2 0.02 57.64 LATENT AUTOIMMUNE DIABETES IN ADULTS | 1 0.01 57.65 LATEX ALLERGY | 1 0.01 57.66 LEFT ATRIAL DILATATION | 1 0.01 57.67 LEFT VENTRICULAR DYSFUNCTION | 5 0.05 57.72 LEFT VENTRICULAR END-DIASTOLIC PRESSU.. | 1 0.01 57.73 LEFT VENTRICULAR HYPERTROPHY | 2 0.02 57.75 LEG AMPUTATION | 1 0.01 57.76 LEPROSY | 1 0.01 57.77 LETHARGY | 6 0.06 57.83 LEUKAEMIA | 1 0.01 57.84 LEUKAEMIA PLASMACYTIC | 1 0.01 57.85 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 57.88 LEUKOCYTOSIS | 9 0.09 57.97 LEUKOENCEPHALOPATHY | 2 0.02 57.99 LEUKOPENIA | 7 0.07 58.06 LIBIDO DECREASED | 2 0.02 58.08 LID LAG | 1 0.01 58.09 LIFE EXPECTANCY SHORTENED | 2 0.02 58.11 LIGAMENT RUPTURE | 2 0.02 58.13 LIMB DEFORMITY | 1 0.01 58.14 LIMB DISCOMFORT | 4 0.04 58.18 LIMB INJURY | 2 0.02 58.20 LIMB OPERATION | 1 0.01 58.21 LIP OEDEMA | 3 0.03 58.24 LIP SWELLING | 3 0.03 58.27 LIPASE INCREASED | 4 0.04 58.31 LISTLESS | 2 0.02 58.33 LIVE BIRTH | 1 0.01 58.34 LIVER CARCINOMA RUPTURED | 1 0.01 58.35 LIVER DISORDER | 19 0.19 58.54 LIVER FUNCTION TEST ABNORMAL | 7 0.07 58.61 LIVER INJURY | 3 0.03 58.64 LOBAR PNEUMONIA | 2 0.02 58.66 LOCAL SWELLING | 1 0.01 58.67 LOCALISED OEDEMA | 1 0.01 58.68 LOOSE TOOTH | 3 0.03 58.71 LOSS OF CONSCIOUSNESS | 29 0.29 59.00 LOSS OF LIBIDO | 2 0.02 59.02 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 59.03 LOW TURNOVER OSTEOPATHY | 5 0.05 59.08 LOWER EXTREMITY MASS | 1 0.01 59.09 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 59.10 LOWER LIMB FRACTURE | 4 0.04 59.14 LOWER RESPIRATORY TRACT INFECTION | 5 0.05 59.19 LOWER RESPIRATORY TRACT INFECTION FUN.. | 1 0.01 59.20 LUMBAR RADICULOPATHY | 2 0.02 59.22 LUMBAR SPINAL STENOSIS | 3 0.03 59.25 LUNG CANCER METASTATIC | 1 0.01 59.26 LUNG DISORDER | 9 0.09 59.35 LUNG INFECTION | 2 0.02 59.37 LUNG INFILTRATION | 3 0.03 59.40 LUNG NEOPLASM | 4 0.04 59.44 LUNG NEOPLASM MALIGNANT | 12 0.12 59.56 LUPUS NEPHRITIS | 1 0.01 59.57 LYME DISEASE | 1 0.01 59.58 LYMPHADENOPATHY | 8 0.08 59.66 LYMPHOCYTE COUNT | 1 0.01 59.67 LYMPHOCYTE COUNT DECREASED | 2 0.02 59.69 LYMPHOCYTE COUNT INCREASED | 1 0.01 59.70 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 59.71 LYMPHOCYTIC INFILTRATION | 1 0.01 59.72 LYMPHOEDEMA | 2 0.02 59.74 LYMPHOMA | 3 0.03 59.77 LYMPHOPENIA | 5 0.05 59.82 MACROCYTOSIS | 2 0.02 59.84 MACROSOMIA | 1 0.01 59.85 MACULAR DEGENERATION | 1 0.01 59.86 MACULOPATHY | 5 0.05 59.91 MAJOR DEPRESSION | 2 0.02 59.93 MALABSORPTION | 1 0.01 59.94 MALAISE | 64 0.64 60.58 MALIGNANT MELANOMA | 5 0.05 60.63 MALIGNANT NEOPLASM OF THORAX | 1 0.01 60.64 MALIGNANT PLEURAL EFFUSION | 1 0.01 60.65 MALNUTRITION | 4 0.04 60.69 MAMMOPLASTY | 1 0.01 60.70 MANIA | 1 0.01 60.71 MANTLE CELL LYMPHOMA | 1 0.01 60.72 MASS | 2 0.02 60.74 MASTECTOMY | 2 0.02 60.76 MASTICATION DISORDER | 2 0.02 60.78 MASTITIS | 1 0.01 60.79 MATERNAL DRUGS AFFECTING FOETUS | 3 0.03 60.82 MEAN CELL VOLUME ABNORMAL | 1 0.01 60.83 MEDICAL DEVICE COMPLICATION | 3 0.03 60.86 MEDICATION ERROR | 3 0.03 60.89 MEDICATION RESIDUE | 4 0.04 60.93 MEGACOLON | 1 0.01 60.94 MELAENA | 10 0.10 61.04 MELANOCYTIC NAEVUS | 2 0.02 61.06 MEMORY IMPAIRMENT | 16 0.16 61.22 MENIERE'S DISEASE | 1 0.01 61.23 MENINGISM | 1 0.01 61.24 MENINGITIS | 1 0.01 61.25 MENINGITIS BACTERIAL | 1 0.01 61.26 MENINGITIS TUBERCULOUS | 1 0.01 61.27 MENINGOENCEPHALITIS HERPETIC | 1 0.01 61.28 MENISCUS LESION | 3 0.03 61.31 MENOPAUSAL SYMPTOMS | 1 0.01 61.32 MENOPAUSE | 2 0.02 61.34 MENORRHAGIA | 4 0.04 61.38 MENSTRUAL DISORDER | 2 0.02 61.40 MENSTRUATION DELAYED | 7 0.07 61.47 MENSTRUATION IRREGULAR | 37 0.37 61.84 MENTAL DISORDER | 12 0.12 61.96 MENTAL IMPAIRMENT | 3 0.03 61.99 MENTAL RETARDATION | 1 0.01 62.00 MENTAL STATUS CHANGES | 5 0.05 62.05 MESENTERITIS | 1 0.01 62.06 METABOLIC ACIDOSIS | 4 0.04 62.10 METABOLIC DISORDER | 2 0.02 62.12 METABOLIC ENCEPHALOPATHY | 1 0.01 62.13 METABOLIC SYNDROME | 3 0.03 62.16 METAPLASIA | 1 0.01 62.17 METASTASES TO BONE | 7 0.07 62.24 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 62.25 METASTASES TO LIVER | 3 0.03 62.28 METASTASES TO LUNG | 1 0.01 62.29 METASTASES TO PITUITARY GLAND | 1 0.01 62.30 METASTASES TO SPINE | 1 0.01 62.31 METASTASES TO STOMACH | 2 0.02 62.33 METASTATIC MALIGNANT MELANOMA | 1 0.01 62.34 METASTATIC NEOPLASM | 1 0.01 62.35 METASTATIC RENAL CELL CARCINOMA | 1 0.01 62.36 MICROANGIOPATHY | 1 0.01 62.37 MICROCEPHALY | 1 0.01 62.38 MICTURITION DISORDER | 1 0.01 62.39 MICTURITION URGENCY | 3 0.03 62.42 MIDDLE EAR EFFUSION | 1 0.01 62.43 MIDDLE INSOMNIA | 1 0.01 62.44 MIGRAINE | 11 0.11 62.55 MILLER FISHER SYNDROME | 1 0.01 62.56 MITRAL VALVE DISEASE | 1 0.01 62.57 MITRAL VALVE INCOMPETENCE | 5 0.05 62.62 MIXED LIVER INJURY | 1 0.01 62.63 MOBILITY DECREASED | 9 0.09 62.72 MONARTHRITIS | 1 0.01 62.73 MONOCYTE COUNT INCREASED | 1 0.01 62.74 MONONUCLEOSIS SYNDROME | 1 0.01 62.75 MONOPLEGIA | 1 0.01 62.76 MOOD ALTERED | 4 0.04 62.80 MOOD SWINGS | 2 0.02 62.82 MOTOR DYSFUNCTION | 6 0.06 62.88 MOUTH BREATHING | 1 0.01 62.89 MOUTH CYST | 1 0.01 62.90 MOUTH ULCERATION | 5 0.05 62.95 MOVEMENT DISORDER | 7 0.07 63.02 MUCOSAL ATROPHY | 1 0.01 63.03 MUCOSAL DRYNESS | 1 0.01 63.04 MUCOSAL INFLAMMATION | 3 0.03 63.07 MUCOSAL ULCERATION | 1 0.01 63.08 MULTI-ORGAN FAILURE | 26 0.26 63.34 MULTIMORBIDITY | 1 0.01 63.35 MULTIPLE DRUG OVERDOSE | 1 0.01 63.36 MULTIPLE DRUG OVERDOSE INTENTIONAL | 4 0.04 63.40 MULTIPLE FRACTURES | 2 0.02 63.42 MULTIPLE MYELOMA | 7 0.07 63.49 MULTIPLE SCLEROSIS | 12 0.12 63.61 MULTIPLE SCLEROSIS RELAPSE | 49 0.49 64.10 MUSCLE CONTRACTURE | 1 0.01 64.11 MUSCLE DISORDER | 5 0.05 64.16 MUSCLE FATIGUE | 1 0.01 64.17 MUSCLE INJURY | 1 0.01 64.18 MUSCLE RIGIDITY | 2 0.02 64.20 MUSCLE RUPTURE | 2 0.02 64.22 MUSCLE SPASMS | 19 0.19 64.41 MUSCLE SPASTICITY | 4 0.04 64.45 MUSCLE STRAIN | 3 0.03 64.48 MUSCLE TIGHTNESS | 3 0.03 64.51 MUSCLE TWITCHING | 1 0.01 64.52 MUSCULAR WEAKNESS | 26 0.26 64.78 MUSCULOSKELETAL CHEST PAIN | 4 0.04 64.82 MUSCULOSKELETAL DISCOMFORT | 10 0.10 64.92 MUSCULOSKELETAL DISORDER | 5 0.05 64.97 MUSCULOSKELETAL PAIN | 10 0.10 65.07 MUSCULOSKELETAL STIFFNESS | 15 0.15 65.22 MUTISM | 2 0.02 65.24 MYALGIA | 36 0.36 65.60 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 65.61 MYCOSIS FUNGOIDES | 1 0.01 65.62 MYDRIASIS | 1 0.01 65.63 MYELODYSPLASTIC SYNDROME | 10 0.10 65.73 MYELODYSPLASTIC SYNDROME TRANSFORMATION | 2 0.02 65.75 MYELOFIBROSIS | 1 0.01 65.76 MYELOPATHY | 1 0.01 65.77 MYOCARDIAL INFARCTION | 53 0.53 66.30 MYOCARDIAL ISCHAEMIA | 1 0.01 66.31 MYOCARDITIS | 3 0.03 66.34 MYOCLONUS | 3 0.03 66.37 MYOSITIS | 2 0.02 66.39 NARCOLEPSY | 1 0.01 66.40 NASAL CONGESTION | 6 0.06 66.46 NASAL DISCOMFORT | 1 0.01 66.47 NASAL MUCOSAL DISORDER | 1 0.01 66.48 NASAL SEPTUM DEVIATION | 1 0.01 66.49 NASOPHARYNGITIS | 16 0.16 66.65 NAUSEA | 93 0.93 67.58 NECK MASS | 2 0.02 67.60 NECK PAIN | 9 0.09 67.69 NECROSIS | 1 0.01 67.70 NECROTISING COLITIS | 1 0.01 67.71 NEGATIVE THOUGHTS | 1 0.01 67.72 NEGATIVISM | 2 0.02 67.74 NEONATAL RESPIRATORY DISTRESS SYNDROME | 2 0.02 67.76 NEONATAL RESPIRATORY FAILURE | 1 0.01 67.77 NEOPLASM | 4 0.04 67.81 NEOPLASM MALIGNANT | 30 0.30 68.11 NEOPLASM SKIN | 1 0.01 68.12 NEPHRITIS | 1 0.01 68.13 NEPHROBLASTOMA | 1 0.01 68.14 NEPHROGENIC ANAEMIA | 1 0.01 68.15 NEPHROGENIC SYSTEMIC FIBROSIS | 4 0.04 68.19 NEPHROLITHIASIS | 13 0.13 68.32 NEPHROPATHY TOXIC | 2 0.02 68.34 NEPHROTIC SYNDROME | 1 0.01 68.35 NERVE COMPRESSION | 4 0.04 68.39 NERVE INJURY | 2 0.02 68.41 NERVE ROOT COMPRESSION | 1 0.01 68.42 NERVOUS SYSTEM DISORDER | 4 0.04 68.46 NERVOUSNESS | 7 0.07 68.53 NEURALGIA | 7 0.07 68.60 NEURITIS CRANIAL | 1 0.01 68.61 NEURODEGENERATIVE DISORDER | 1 0.01 68.62 NEURODERMATITIS | 1 0.01 68.63 NEUROENDOCRINE CARCINOMA | 1 0.01 68.64 NEUROLEPTIC MALIGNANT SYNDROME | 1 0.01 68.65 NEUROMYOPATHY | 1 0.01 68.66 NEUROPATHY PERIPHERAL | 8 0.08 68.74 NEUROTOXICITY | 2 0.02 68.76 NEUTROPENIA | 19 0.19 68.95 NEUTROPENIC SEPSIS | 2 0.02 68.97 NEUTROPHIL COUNT DECREASED | 5 0.05 69.02 NEUTROPHIL COUNT INCREASED | 2 0.02 69.04 NIGHT SWEATS | 1 0.01 69.05 NIGHTMARE | 4 0.04 69.09 NIPPLE PAIN | 1 0.01 69.10 NO ADVERSE EVENT | 17 0.17 69.27 NO THERAPEUTIC RESPONSE | 6 0.06 69.33 NOCTURIA | 1 0.01 69.34 NODAL ARRHYTHMIA | 1 0.01 69.35 NODULAR REGENERATIVE HYPERPLASIA | 1 0.01 69.36 NODULE | 1 0.01 69.37 NON-CARDIAC CHEST PAIN | 2 0.02 69.39 NON-HODGKIN'S LYMPHOMA | 3 0.03 69.42 NONSPECIFIC REACTION | 1 0.01 69.43 NORMAL PRESSURE HYDROCEPHALUS | 1 0.01 69.44 NORMOCHROMIC NORMOCYTIC ANAEMIA | 2 0.02 69.46 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 69.47 OBESITY | 1 0.01 69.48 OBESITY SURGERY | 1 0.01 69.49 OCCULT BLOOD POSITIVE | 1 0.01 69.50 OCULAR DISCOMFORT | 1 0.01 69.51 OCULAR HYPERAEMIA | 2 0.02 69.53 OCULAR HYPERTENSION | 1 0.01 69.54 OCULAR ICTERUS | 3 0.03 69.57 OCULOGYRIC CRISIS | 1 0.01 69.58 ODYNOPHAGIA | 4 0.04 69.62 OEDEMA | 14 0.14 69.76 OEDEMA MOUTH | 1 0.01 69.77 OEDEMA PERIPHERAL | 51 0.51 70.28 OESOPHAGEAL CANDIDIASIS | 2 0.02 70.30 OESOPHAGEAL CARCINOMA | 1 0.01 70.31 OESOPHAGEAL IRRITATION | 1 0.01 70.32 OESOPHAGEAL PAIN | 5 0.05 70.37 OESOPHAGEAL PERFORATION | 1 0.01 70.38 OESOPHAGEAL RUPTURE | 1 0.01 70.39 OESOPHAGEAL SPASM | 1 0.01 70.40 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 1 0.01 70.41 OESOPHAGEAL STENOSIS | 1 0.01 70.42 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 70.43 OESOPHAGITIS | 6 0.06 70.49 OESOPHAGITIS ULCERATIVE | 1 0.01 70.50 OESTROGEN RECEPTOR ASSAY POSITIVE | 2 0.02 70.52 OFF LABEL USE | 18 0.18 70.70 OLIGODIPSIA | 2 0.02 70.72 OLIGURIA | 3 0.03 70.75 ONYCHOMADESIS | 1 0.01 70.76 ONYCHOMYCOSIS | 3 0.03 70.79 OOPHORECTOMY | 1 0.01 70.80 OOPHORECTOMY BILATERAL | 1 0.01 70.81 OPEN FRACTURE | 1 0.01 70.82 OPEN WOUND | 1 0.01 70.83 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 70.84 OPTIC NEURITIS | 3 0.03 70.87 ORAL CANDIDIASIS | 2 0.02 70.89 ORAL DISORDER | 5 0.05 70.94 ORAL FUNGAL INFECTION | 1 0.01 70.95 ORAL HERPES | 3 0.03 70.98 ORAL INFECTION | 4 0.04 71.02 ORAL MUCOSAL EXFOLIATION | 1 0.01 71.03 ORAL PAIN | 7 0.07 71.10 ORAL PAPILLOMA | 1 0.01 71.11 ORAL TORUS | 2 0.02 71.13 ORGAN FAILURE | 3 0.03 71.16 ORGASM ABNORMAL | 1 0.01 71.17 OROANTRAL FISTULA | 1 0.01 71.18 OROPHARYNGEAL BLISTERING | 1 0.01 71.19 OROPHARYNGEAL PAIN | 12 0.12 71.31 OROPHARYNGEAL PLAQUE | 2 0.02 71.33 OROPHARYNGEAL SPASM | 1 0.01 71.34 ORTHOSIS USER | 1 0.01 71.35 ORTHOSTATIC HYPOTENSION | 3 0.03 71.38 OSTEITIS | 2 0.02 71.40 OSTEOARTHRITIS | 11 0.11 71.51 OSTEOMALACIA | 1 0.01 71.52 OSTEOMYELITIS | 11 0.11 71.63 OSTEONECROSIS | 3 0.03 71.66 OSTEONECROSIS OF JAW | 21 0.21 71.87 OSTEOPENIA | 7 0.07 71.94 OSTEOPOROSIS | 10 0.10 72.04 OTITIS EXTERNA | 2 0.02 72.06 OTITIS MEDIA | 1 0.01 72.07 OTORRHOEA | 3 0.03 72.10 OVARIAN CANCER | 1 0.01 72.11 OVARIAN CYST | 3 0.03 72.14 OVARIAN CYST TORSION | 1 0.01 72.15 OVARIAN DISORDER | 1 0.01 72.16 OVERDOSE | 25 0.25 72.41 OVERWEIGHT | 1 0.01 72.42 OXYGEN CONSUMPTION INCREASED | 2 0.02 72.44 OXYGEN SATURATION DECREASED | 8 0.08 72.52 OXYGEN SUPPLEMENTATION | 1 0.01 72.53 PAIN | 140 1.40 73.93 PAIN IN EXTREMITY | 63 0.63 74.56 PAIN IN JAW | 6 0.06 74.62 PAINFUL DEFAECATION | 1 0.01 74.63 PALATAL DISORDER | 1 0.01 74.64 PALLIATIVE CARE | 1 0.01 74.65 PALLOR | 3 0.03 74.68 PALMAR ERYTHEMA | 1 0.01 74.69 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 7 0.07 74.76 PALPITATIONS | 14 0.14 74.90 PANCREATIC CARCINOMA | 3 0.03 74.93 PANCREATIC CYST | 1 0.01 74.94 PANCREATIC DISORDER | 1 0.01 74.95 PANCREATIC ENZYMES INCREASED | 1 0.01 74.96 PANCREATIC PSEUDOCYST | 1 0.01 74.97 PANCREATITIS | 5 0.05 75.02 PANCREATITIS ACUTE | 6 0.06 75.08 PANCREATITIS CHRONIC | 1 0.01 75.09 PANCREATITIS NECROTISING | 1 0.01 75.10 PANCYTOPENIA | 10 0.10 75.20 PANIC ATTACK | 3 0.03 75.23 PARAESTHESIA | 18 0.18 75.41 PARAESTHESIA ORAL | 1 0.01 75.42 PARAKERATOSIS | 1 0.01 75.43 PARALYSIS | 4 0.04 75.47 PARANOIA | 1 0.01 75.48 PARAPLEGIA | 3 0.03 75.51 PARESIS | 4 0.04 75.55 PARKINSON'S DISEASE | 3 0.03 75.58 PARKINSONISM | 1 0.01 75.59 PARONYCHIA | 2 0.02 75.61 PAROTID GLAND ENLARGEMENT | 3 0.03 75.64 PAROTITIS | 2 0.02 75.66 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 1 0.01 75.67 PARTIAL SEIZURES | 1 0.01 75.68 PATELLA FRACTURE | 2 0.02 75.70 PATENT DUCTUS ARTERIOSUS | 1 0.01 75.71 PATHOLOGICAL FRACTURE | 1 0.01 75.72 PELVIC FRACTURE | 6 0.06 75.78 PELVIC PAIN | 5 0.05 75.83 PENIS DISORDER | 1 0.01 75.84 PEPTIC ULCER | 1 0.01 75.85 PERFORMANCE STATUS DECREASED | 1 0.01 75.86 PERIARTHRITIS | 2 0.02 75.88 PERICARDIAL DISEASE | 1 0.01 75.89 PERICARDIAL EFFUSION | 8 0.08 75.97 PERICARDIAL HAEMORRHAGE | 1 0.01 75.98 PERICARDITIS | 1 0.01 75.99 PERIODONTAL DISEASE | 1 0.01 76.00 PERIODONTITIS | 2 0.02 76.02 PERIORBITAL HAEMATOMA | 1 0.01 76.03 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 3 0.03 76.06 PERIPHERAL COLDNESS | 1 0.01 76.07 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 76.08 PERIPHERAL SENSORIMOTOR NEUROPATHY | 1 0.01 76.09 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 76.10 PERITONEAL DIALYSIS COMPLICATION | 3 0.03 76.13 PERITONITIS | 4 0.04 76.17 PERITONITIS BACTERIAL | 3 0.03 76.20 PERONEAL NERVE PALSY | 2 0.02 76.22 PERSONALITY CHANGE | 1 0.01 76.23 PERTUSSIS | 1 0.01 76.24 PETECHIAE | 1 0.01 76.25 PETIT MAL EPILEPSY | 3 0.03 76.28 PHARYNGEAL OEDEMA | 3 0.03 76.31 PHARYNGITIS | 1 0.01 76.32 PHLEBITIS | 2 0.02 76.34 PHONOPHOBIA | 1 0.01 76.35 PHOTODERMATOSIS | 1 0.01 76.36 PHOTOPHOBIA | 6 0.06 76.42 PHOTOPSIA | 2 0.02 76.44 PILONIDAL CYST | 1 0.01 76.45 PITYRIASIS LICHENOIDES ET VARIOLIFORM.. | 1 0.01 76.46 PLACENTA ACCRETA | 1 0.01 76.47 PLACENTA PRAEVIA | 1 0.01 76.48 PLACENTAL DISORDER | 1 0.01 76.49 PLACENTAL INFARCTION | 1 0.01 76.50 PLACENTAL INSUFFICIENCY | 1 0.01 76.51 PLANTAR FASCIITIS | 2 0.02 76.53 PLATELET COUNT ABNORMAL | 1 0.01 76.54 PLATELET COUNT DECREASED | 20 0.20 76.74 PLATELET COUNT INCREASED | 1 0.01 76.75 PLEURAL EFFUSION | 18 0.18 76.93 PLEURITIC PAIN | 2 0.02 76.95 PNEUMATOSIS INTESTINALIS | 4 0.04 76.99 PNEUMOCOCCAL INFECTION | 1 0.01 77.00 PNEUMOCYSTIS JIROVECI PNEUMONIA | 3 0.03 77.03 PNEUMOMEDIASTINUM | 1 0.01 77.04 PNEUMONIA | 72 0.72 77.76 PNEUMONIA ASPIRATION | 6 0.06 77.82 PNEUMONIA BACTERIAL | 2 0.02 77.84 PNEUMONIA FUNGAL | 1 0.01 77.85 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 77.86 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL | 1 0.01 77.87 PNEUMONITIS | 7 0.07 77.94 PNEUMOPERITONEUM | 1 0.01 77.95 PNEUMOTHORAX | 3 0.03 77.98 POISONING | 2 0.02 78.00 POLLAKIURIA | 5 0.05 78.05 POLYARTHRITIS | 4 0.04 78.09 POLYCYSTIC OVARIES | 1 0.01 78.10 POLYDIPSIA | 1 0.01 78.11 POLYMYOSITIS | 1 0.01 78.12 POLYNEUROPATHY | 3 0.03 78.15 POLYP | 1 0.01 78.16 POLYURIA | 1 0.01 78.17 POOR PERIPHERAL CIRCULATION | 1 0.01 78.18 POOR PERSONAL HYGIENE | 2 0.02 78.20 POOR QUALITY SLEEP | 4 0.04 78.24 PORTAL VEIN THROMBOSIS | 1 0.01 78.25 POST CHOLECYSTECTOMY SYNDROME | 1 0.01 78.26 POST PROCEDURAL COMPLICATION | 2 0.02 78.28 POST PROCEDURAL HAEMORRHAGE | 2 0.02 78.30 POST PROCEDURAL INFECTION | 1 0.01 78.31 POST-TRAUMATIC PAIN | 1 0.01 78.32 POSTERIOR CAPSULE OPACIFICATION | 1 0.01 78.33 POSTERIOR REVERSIBLE ENCEPHALOPATHY S.. | 5 0.05 78.38 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 78.39 POSTOPERATIVE ADHESION | 1 0.01 78.40 POSTPARTUM DEPRESSION | 2 0.02 78.42 POSTPERICARDIOTOMY SYNDROME | 1 0.01 78.43 POSTURE ABNORMAL | 1 0.01 78.44 PRE-ECLAMPSIA | 2 0.02 78.46 PREGNANCY | 8 0.08 78.54 PREGNANCY ON ORAL CONTRACEPTIVE | 2 0.02 78.56 PREGNANCY WITH CONTRACEPTIVE DEVICE | 4 0.04 78.60 PREMATURE BABY | 4 0.04 78.64 PREMATURE LABOUR | 2 0.02 78.66 PREMATURE RUPTURE OF MEMBRANES | 1 0.01 78.67 PREMATURE SEPARATION OF PLACENTA | 1 0.01 78.68 PREMENSTRUAL SYNDROME | 2 0.02 78.70 PRESSURE OF SPEECH | 2 0.02 78.72 PRESYNCOPE | 4 0.04 78.76 PRIAPISM | 1 0.01 78.77 PRIMARY SEQUESTRUM | 5 0.05 78.82 PROCEDURAL COMPLICATION | 1 0.01 78.83 PROCEDURAL HYPERTENSION | 1 0.01 78.84 PROCEDURAL PAIN | 6 0.06 78.90 PRODUCT ADHESION ISSUE | 3 0.03 78.93 PRODUCT COLOUR ISSUE | 1 0.01 78.94 PRODUCT ODOUR ABNORMAL | 1 0.01 78.95 PRODUCT QUALITY ISSUE | 13 0.13 79.08 PRODUCT SIZE ISSUE | 1 0.01 79.09 PRODUCT SUBSTITUTION ISSUE | 1 0.01 79.10 PRODUCT TASTE ABNORMAL | 2 0.02 79.12 PRODUCTIVE COUGH | 6 0.06 79.18 PROGESTERONE RECEPTOR ASSAY POSITIVE | 2 0.02 79.20 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 9 0.09 79.29 PROLACTINOMA | 1 0.01 79.30 PROSTATE CANCER | 6 0.06 79.36 PROSTATIC OBSTRUCTION | 1 0.01 79.37 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 79.39 PROSTATITIS | 1 0.01 79.40 PROSTHESIS USER | 1 0.01 79.41 PROTEIN TOTAL DECREASED | 1 0.01 79.42 PROTEIN URINE PRESENT | 1 0.01 79.43 PROTEIN-LOSING GASTROENTEROPATHY | 1 0.01 79.44 PROTEINURIA | 5 0.05 79.49 PRURITUS | 32 0.32 79.81 PRURITUS GENERALISED | 6 0.06 79.87 PRURITUS GENITAL | 1 0.01 79.88 PSEUDOMEMBRANOUS COLITIS | 2 0.02 79.90 PSEUDOMONAL SEPSIS | 3 0.03 79.93 PSEUDOMONAS INFECTION | 3 0.03 79.96 PSORIASIS | 10 0.10 80.06 PSYCHIATRIC DECOMPENSATION | 2 0.02 80.08 PSYCHIATRIC SYMPTOM | 1 0.01 80.09 PSYCHOTIC DISORDER | 7 0.07 80.16 PTERYGIUM | 1 0.01 80.17 PUBIS FRACTURE | 1 0.01 80.18 PULMONARY ARTERIAL HYPERTENSION | 1 0.01 80.19 PULMONARY CONGESTION | 1 0.01 80.20 PULMONARY EMBOLISM | 37 0.37 80.57 PULMONARY FIBROSIS | 4 0.04 80.61 PULMONARY HYPERTENSION | 3 0.03 80.64 PULMONARY INFARCTION | 1 0.01 80.65 PULMONARY MASS | 1 0.01 80.66 PULMONARY MYCOSIS | 1 0.01 80.67 PULMONARY OEDEMA | 10 0.10 80.77 PULMONARY TUBERCULOSIS | 2 0.02 80.79 PULMONARY VASCULAR DISORDER | 1 0.01 80.80 PULPITIS DENTAL | 1 0.01 80.81 PULSE ABSENT | 2 0.02 80.83 PULSELESS ELECTRICAL ACTIVITY | 1 0.01 80.84 PUPIL FIXED | 1 0.01 80.85 PUPILLARY REFLEX IMPAIRED | 1 0.01 80.86 PURPURA | 2 0.02 80.88 PURULENCE | 1 0.01 80.89 PURULENT DISCHARGE | 3 0.03 80.92 PUSTULAR PSORIASIS | 1 0.01 80.93 PYELONEPHRITIS ACUTE | 1 0.01 80.94 PYLORIC STENOSIS | 2 0.02 80.96 PYOTHORAX | 1 0.01 80.97 PYREXIA | 79 0.79 81.76 QUADRIPARESIS | 2 0.02 81.78 RADICULOPATHY | 1 0.01 81.79 RALES | 2 0.02 81.81 RASH | 49 0.49 82.30 RASH ERYTHEMATOUS | 2 0.02 82.32 RASH GENERALISED | 5 0.05 82.37 RASH MACULAR | 3 0.03 82.40 RASH MACULO-PAPULAR | 4 0.04 82.44 RASH PAPULAR | 1 0.01 82.45 RASH PRURITIC | 3 0.03 82.48 RASH PUSTULAR | 2 0.02 82.50 RASH VESICULAR | 1 0.01 82.51 REACTION TO COLOURING | 1 0.01 82.52 RECTAL CANCER | 1 0.01 82.53 RECTAL CANCER STAGE III | 1 0.01 82.54 RECTAL HAEMORRHAGE | 13 0.13 82.67 RECTAL PERFORATION | 3 0.03 82.70 RECTAL POLYP | 1 0.01 82.71 RECTAL TENESMUS | 1 0.01 82.72 RED BLOOD CELL COUNT ABNORMAL | 1 0.01 82.73 RED BLOOD CELL COUNT DECREASED | 5 0.05 82.78 RED BLOOD CELL SEDIMENTATION RATE INC.. | 1 0.01 82.79 RED BLOOD CELLS URINE | 1 0.01 82.80 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 82.81 REFLUX OESOPHAGITIS | 1 0.01 82.82 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 1 0.01 82.83 RENAL ABSCESS | 1 0.01 82.84 RENAL ARTERY OCCLUSION | 1 0.01 82.85 RENAL CANCER | 2 0.02 82.87 RENAL CELL CARCINOMA | 3 0.03 82.90 RENAL CYST | 5 0.05 82.95 RENAL DISORDER | 9 0.09 83.04 RENAL FAILURE | 51 0.51 83.55 RENAL FAILURE ACUTE | 26 0.26 83.81 RENAL FAILURE CHRONIC | 4 0.04 83.85 RENAL IMPAIRMENT | 28 0.28 84.13 RENAL INJURY | 19 0.19 84.32 RENAL MASS | 1 0.01 84.33 RENAL PAIN | 5 0.05 84.38 RENAL TUBULAR ACIDOSIS | 1 0.01 84.39 RENAL TUBULAR DISORDER | 1 0.01 84.40 RENAL TUBULAR NECROSIS | 2 0.02 84.42 REPETITIVE SPEECH | 1 0.01 84.43 RESORPTION BONE INCREASED | 1 0.01 84.44 RESPIRATORY ACIDOSIS | 1 0.01 84.45 RESPIRATORY ARREST | 8 0.08 84.53 RESPIRATORY DEPRESSION | 5 0.05 84.58 RESPIRATORY DISORDER | 4 0.04 84.62 RESPIRATORY DISTRESS | 4 0.04 84.66 RESPIRATORY FAILURE | 18 0.18 84.84 RESPIRATORY RATE INCREASED | 1 0.01 84.85 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOL.. | 1 0.01 84.86 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 84.87 RESPIRATORY SYNCYTIAL VIRUS TEST POSI.. | 2 0.02 84.89 RESPIRATORY TRACT INFECTION | 6 0.06 84.95 RESPIRATORY TRACT OEDEMA | 1 0.01 84.96 RESTLESS LEGS SYNDROME | 6 0.06 85.02 RESTLESSNESS | 6 0.06 85.08 RESUSCITATION | 2 0.02 85.10 RETINAL DETACHMENT | 2 0.02 85.12 RETINAL DISORDER | 2 0.02 85.14 RETINAL ISCHAEMIA | 2 0.02 85.16 RETINAL OEDEMA | 1 0.01 85.17 RHABDOMYOLYSIS | 11 0.11 85.28 RHEUMATOID ARTHRITIS | 14 0.14 85.42 RHEUMATOID FACTOR INCREASED | 1 0.01 85.43 RHINORRHOEA | 4 0.04 85.47 RHONCHI | 1 0.01 85.48 RIB FRACTURE | 12 0.12 85.60 RIGHT VENTRICULAR FAILURE | 2 0.02 85.62 ROAD TRAFFIC ACCIDENT | 8 0.08 85.70 ROTATOR CUFF SYNDROME | 11 0.11 85.81 SALIVARY GLAND CALCULUS | 1 0.01 85.82 SALIVARY GLAND ENLARGEMENT | 1 0.01 85.83 SALIVARY GLAND NEOPLASM | 1 0.01 85.84 SALIVARY HYPERSECRETION | 1 0.01 85.85 SALMONELLA SEPSIS | 1 0.01 85.86 SARCOIDOSIS | 4 0.04 85.90 SARCOMA | 1 0.01 85.91 SCAB | 2 0.02 85.93 SCAR | 5 0.05 85.98 SCHIZOPHRENIA | 1 0.01 85.99 SCIATICA | 3 0.03 86.02 SCOLIOSIS | 6 0.06 86.08 SCRATCH | 1 0.01 86.09 SCROTAL OEDEMA | 1 0.01 86.10 SCROTAL SWELLING | 1 0.01 86.11 SEASONAL ALLERGY | 2 0.02 86.13 SEBORRHOEA | 1 0.01 86.14 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 86.15 SECRETION DISCHARGE | 2 0.02 86.17 SEDATION | 5 0.05 86.22 SELECTIVE ABORTION | 1 0.01 86.23 SELF INJURIOUS BEHAVIOUR | 3 0.03 86.26 SELF-MEDICATION | 2 0.02 86.28 SENILE OSTEOPOROSIS | 1 0.01 86.29 SENSATION OF FOREIGN BODY | 1 0.01 86.30 SENSATION OF HEAVINESS | 3 0.03 86.33 SENSATION OF PRESSURE | 1 0.01 86.34 SENSORY DISTURBANCE | 3 0.03 86.37 SENSORY LEVEL ABNORMAL | 1 0.01 86.38 SENSORY LOSS | 2 0.02 86.40 SEPSIS | 31 0.31 86.71 SEPTIC EMBOLUS | 1 0.01 86.72 SEPTIC SHOCK | 15 0.15 86.87 SEROMA | 1 0.01 86.88 SEROTONIN SYNDROME | 2 0.02 86.90 SERUM FERRITIN DECREASED | 1 0.01 86.91 SERUM FERRITIN INCREASED | 1 0.01 86.92 SERUM SICKNESS | 1 0.01 86.93 SEXUAL DYSFUNCTION | 1 0.01 86.94 SEXUALLY INAPPROPRIATE BEHAVIOUR | 1 0.01 86.95 SHOCK | 5 0.05 87.00 SHOULDER ARTHROPLASTY | 1 0.01 87.01 SHOULDER DYSTOCIA | 1 0.01 87.02 SHOULDER OPERATION | 1 0.01 87.03 SHUNT THROMBOSIS | 1 0.01 87.04 SIALOADENITIS | 1 0.01 87.05 SICK SINUS SYNDROME | 4 0.04 87.09 SICKLE CELL ANAEMIA WITH CRISIS | 2 0.02 87.11 SIMPLEX VIRUS TEST POSITIVE | 1 0.01 87.12 SINOBRONCHITIS | 1 0.01 87.13 SINUS ARREST | 1 0.01 87.14 SINUS BRADYCARDIA | 1 0.01 87.15 SINUS CONGESTION | 2 0.02 87.17 SINUS DISORDER | 4 0.04 87.21 SINUS HEADACHE | 3 0.03 87.24 SINUSITIS | 17 0.17 87.41 SJOGREN'S SYNDROME | 3 0.03 87.44 SKELETAL INJURY | 1 0.01 87.45 SKIN ATROPHY | 1 0.01 87.46 SKIN BURNING SENSATION | 3 0.03 87.49 SKIN CANCER | 3 0.03 87.52 SKIN DISCOLOURATION | 10 0.10 87.62 SKIN DISORDER | 8 0.08 87.70 SKIN EROSION | 1 0.01 87.71 SKIN EXFOLIATION | 5 0.05 87.76 SKIN FISSURES | 1 0.01 87.77 SKIN GRAFT | 1 0.01 87.78 SKIN HAEMORRHAGE | 4 0.04 87.82 SKIN HYPERPIGMENTATION | 2 0.02 87.84 SKIN INDURATION | 2 0.02 87.86 SKIN INJURY | 2 0.02 87.88 SKIN LESION | 2 0.02 87.90 SKIN NECROSIS | 2 0.02 87.92 SKIN ODOUR ABNORMAL | 2 0.02 87.94 SKIN PAPILLOMA | 2 0.02 87.96 SKIN REACTION | 3 0.03 87.99 SKIN SWELLING | 1 0.01 88.00 SKIN TIGHTNESS | 3 0.03 88.03 SKIN TOXICITY | 2 0.02 88.05 SKIN ULCER | 2 0.02 88.07 SKIN WARM | 1 0.01 88.08 SLEEP APNOEA SYNDROME | 3 0.03 88.11 SLEEP DISORDER | 8 0.08 88.19 SMALL CELL LUNG CANCER LIMITED STAGE | 1 0.01 88.20 SMALL FOR DATES BABY | 1 0.01 88.21 SMALL INTESTINAL HAEMORRHAGE | 1 0.01 88.22 SMALL INTESTINAL OBSTRUCTION | 1 0.01 88.23 SMALL INTESTINAL STENOSIS | 1 0.01 88.24 SOCIAL AVOIDANT BEHAVIOUR | 2 0.02 88.26 SOFT TISSUE INFECTION | 1 0.01 88.27 SOFT TISSUE NEOPLASM | 1 0.01 88.28 SOMATOSENSORY EVOKED POTENTIALS ABNOR.. | 1 0.01 88.29 SOMNOLENCE | 23 0.23 88.52 SPEECH DISORDER | 12 0.12 88.64 SPINAL COLUMN INJURY | 1 0.01 88.65 SPINAL COLUMN STENOSIS | 1 0.01 88.66 SPINAL COMPRESSION FRACTURE | 3 0.03 88.69 SPINAL CORD COMPRESSION | 2 0.02 88.71 SPINAL CORD DISORDER | 1 0.01 88.72 SPINAL CORD INJURY | 1 0.01 88.73 SPINAL CORD NEOPLASM | 1 0.01 88.74 SPINAL DEFORMITY | 1 0.01 88.75 SPINAL DISORDER | 2 0.02 88.77 SPINAL FRACTURE | 5 0.05 88.82 SPINAL FUSION ACQUIRED | 1 0.01 88.83 SPINAL HAEMANGIOMA | 1 0.01 88.84 SPINAL MENINGEAL CYST | 1 0.01 88.85 SPINAL OSTEOARTHRITIS | 10 0.10 88.95 SPLEEN TUBERCULOSIS | 1 0.01 88.96 SPLENOMEGALY | 1 0.01 88.97 SPLINT APPLICATION | 1 0.01 88.98 SPONDYLOLISTHESIS | 3 0.03 89.01 SPONTANEOUS HAEMATOMA | 1 0.01 89.02 SQUAMOUS CELL CARCINOMA | 4 0.04 89.06 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 89.07 STAPHYLOCOCCAL BACTERAEMIA | 2 0.02 89.09 STAPHYLOCOCCAL INFECTION | 13 0.13 89.22 STAPHYLOCOCCAL SEPSIS | 1 0.01 89.23 STAPHYLOCOCCUS TEST POSITIVE | 1 0.01 89.24 STARING | 2 0.02 89.26 STASIS DERMATITIS | 1 0.01 89.27 STATUS EPILEPTICUS | 1 0.01 89.28 STENOTROPHOMONAS INFECTION | 1 0.01 89.29 STENT PLACEMENT | 2 0.02 89.31 STEVENS-JOHNSON SYNDROME | 3 0.03 89.34 STILLBIRTH | 3 0.03 89.37 STOMATITIS | 7 0.07 89.44 STREPTOCOCCAL INFECTION | 1 0.01 89.45 STRESS | 34 0.34 89.79 STRESS CARDIOMYOPATHY | 1 0.01 89.80 STRESS FRACTURE | 5 0.05 89.85 STRIDOR | 1 0.01 89.86 STUPOR | 1 0.01 89.87 SUBARACHNOID HAEMORRHAGE | 2 0.02 89.89 SUBCUTANEOUS ABSCESS | 2 0.02 89.91 SUBDURAL HAEMATOMA | 3 0.03 89.94 SUBDURAL HAEMORRHAGE | 1 0.01 89.95 SUBILEUS | 1 0.01 89.96 SUBSTANCE ABUSE | 2 0.02 89.98 SUDDEN CARDIAC DEATH | 2 0.02 90.00 SUDDEN DEATH | 3 0.03 90.03 SUDDEN ONSET OF SLEEP | 1 0.01 90.04 SUFFOCATION FEELING | 1 0.01 90.05 SUICIDAL BEHAVIOUR | 1 0.01 90.06 SUICIDAL IDEATION | 23 0.23 90.29 SUICIDE ATTEMPT | 9 0.09 90.38 SUPERIOR SAGITTAL SINUS THROMBOSIS | 2 0.02 90.40 SUPERIOR VENA CAVA SYNDROME | 1 0.01 90.41 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 90.42 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 90.45 SURGERY | 5 0.05 90.50 SWELLING | 12 0.12 90.62 SWELLING FACE | 10 0.10 90.72 SWOLLEN TONGUE | 7 0.07 90.79 SYNCOPE | 26 0.26 91.05 SYNDACTYLY | 1 0.01 91.06 SYNOVITIS | 1 0.01 91.07 SYSTEMIC CANDIDA | 1 0.01 91.08 SYSTEMIC LUPUS ERYTHEMATOSUS | 8 0.08 91.16 SYSTEMIC SCLEROSIS | 1 0.01 91.17 TACHYCARDIA | 14 0.14 91.31 TACHYPNOEA | 1 0.01 91.32 TACITURNITY | 1 0.01 91.33 TARDIVE DYSKINESIA | 5 0.05 91.38 TEAR DISCOLOURATION | 1 0.01 91.39 TEARFULNESS | 1 0.01 91.40 TEMPERATURE INTOLERANCE | 1 0.01 91.41 TEMPORAL LOBE EPILEPSY | 1 0.01 91.42 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 91.43 TENDERNESS | 1 0.01 91.44 TENDON DISORDER | 2 0.02 91.46 TENDON INJURY | 1 0.01 91.47 TENDON RUPTURE | 4 0.04 91.51 TENDONITIS | 7 0.07 91.58 TENOSYNOVITIS STENOSANS | 1 0.01 91.59 TENSION | 2 0.02 91.61 TERMINAL STATE | 1 0.01 91.62 TESTICULAR HYPERTROPHY | 1 0.01 91.63 TESTICULAR SEMINOMA (PURE) | 1 0.01 91.64 THERAPEUTIC PROCEDURE | 1 0.01 91.65 THERAPEUTIC RESPONSE DECREASED | 4 0.04 91.69 THERAPEUTIC RESPONSE DELAYED | 2 0.02 91.71 THERAPEUTIC RESPONSE UNEXPECTED | 2 0.02 91.73 THERMAL BURN | 2 0.02 91.75 THERMOANAESTHESIA | 1 0.01 91.76 THINKING ABNORMAL | 2 0.02 91.78 THIRST | 1 0.01 91.79 THROAT CANCER | 1 0.01 91.80 THROAT IRRITATION | 6 0.06 91.86 THROAT LESION | 1 0.01 91.87 THROAT TIGHTNESS | 5 0.05 91.92 THROMBOCYTOPENIA | 31 0.31 92.23 THROMBOCYTOPENIC PURPURA | 1 0.01 92.24 THROMBOCYTOSIS | 1 0.01 92.25 THROMBOLYSIS | 1 0.01 92.26 THROMBOPHLEBITIS | 1 0.01 92.27 THROMBOPHLEBITIS SUPERFICIAL | 2 0.02 92.29 THROMBOSIS | 15 0.15 92.44 THROMBOSIS IN DEVICE | 1 0.01 92.45 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 92.47 THYROID CYST | 2 0.02 92.49 THYROID DISORDER | 2 0.02 92.51 THYROID FUNCTION TEST ABNORMAL | 1 0.01 92.52 THYROID NEOPLASM | 2 0.02 92.54 THYROIDECTOMY | 1 0.01 92.55 THYROIDITIS | 6 0.06 92.61 THYROTOXIC CRISIS | 1 0.01 92.62 THYROXINE FREE DECREASED | 1 0.01 92.63 TIBIA FRACTURE | 4 0.04 92.67 TINEA CRURIS | 1 0.01 92.68 TINEL'S SIGN | 1 0.01 92.69 TINNITUS | 8 0.08 92.77 TOBACCO ABUSE | 1 0.01 92.78 TONGUE BLISTERING | 1 0.01 92.79 TONGUE COATED | 1 0.01 92.80 TONGUE DISCOLOURATION | 1 0.01 92.81 TONGUE DISORDER | 2 0.02 92.83 TONGUE INJURY | 1 0.01 92.84 TONGUE OEDEMA | 3 0.03 92.87 TONGUE ULCERATION | 1 0.01 92.88 TONSILLITIS | 2 0.02 92.90 TOOTH ABSCESS | 3 0.03 92.93 TOOTH DEPOSIT | 1 0.01 92.94 TOOTH DISCOLOURATION | 1 0.01 92.95 TOOTH DISORDER | 3 0.03 92.98 TOOTH EROSION | 2 0.02 93.00 TOOTH EXTRACTION | 1 0.01 93.01 TOOTH FRACTURE | 4 0.04 93.05 TOOTH INFECTION | 2 0.02 93.07 TOOTH LOSS | 9 0.09 93.16 TOOTHACHE | 4 0.04 93.20 TORSADE DE POINTES | 3 0.03 93.23 TORTICOLLIS | 1 0.01 93.24 TOTAL CHOLESTEROL/HDL RATIO DECREASED | 1 0.01 93.25 TOTAL LUNG CAPACITY DECREASED | 1 0.01 93.26 TOXIC ENCEPHALOPATHY | 1 0.01 93.27 TOXIC EPIDERMAL NECROLYSIS | 1 0.01 93.28 TOXIC SKIN ERUPTION | 1 0.01 93.29 TOXICITY TO VARIOUS AGENTS | 13 0.13 93.42 TOXOPLASMOSIS | 1 0.01 93.43 TRANSAMINASES ABNORMAL | 1 0.01 93.44 TRANSAMINASES INCREASED | 3 0.03 93.47 TRANSIENT ISCHAEMIC ATTACK | 20 0.20 93.67 TRANSITIONAL CELL CARCINOMA | 1 0.01 93.68 TRANSPLANT REJECTION | 1 0.01 93.69 TRAUMATIC LUNG INJURY | 1 0.01 93.70 TREATMENT NONCOMPLIANCE | 9 0.09 93.79 TREMOR | 30 0.30 94.09 TREMOR NEONATAL | 1 0.01 94.10 TRICUSPID VALVE DISEASE | 1 0.01 94.11 TRICUSPID VALVE INCOMPETENCE | 3 0.03 94.14 TRIGEMINAL NEURALGIA | 1 0.01 94.15 TRIGGER FINGER | 1 0.01 94.16 TRISMUS | 1 0.01 94.17 TRISOMY 21 | 1 0.01 94.18 TROPONIN I INCREASED | 1 0.01 94.19 TROPONIN INCREASED | 2 0.02 94.21 TUBERCULOSIS | 3 0.03 94.24 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM | 1 0.01 94.25 TUBULOINTERSTITIAL NEPHRITIS | 4 0.04 94.29 TUMOUR EXCISION | 1 0.01 94.30 TUMOUR INVASION | 1 0.01 94.31 TUMOUR LYSIS SYNDROME | 3 0.03 94.34 TYMPANIC MEMBRANE PERFORATION | 1 0.01 94.35 TYPE 2 DIABETES MELLITUS | 14 0.14 94.49 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 94.50 ULCER | 5 0.05 94.55 ULCER HAEMORRHAGE | 2 0.02 94.57 UMBILICAL HERNIA | 2 0.02 94.59 UNDERDOSE | 1 0.01 94.60 UNEVALUABLE EVENT | 26 0.26 94.86 UNINTENDED PREGNANCY | 3 0.03 94.89 UNRESPONSIVE TO STIMULI | 7 0.07 94.96 UPPER AIRWAY OBSTRUCTION | 1 0.01 94.97 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 94.98 UPPER LIMB FRACTURE | 5 0.05 95.03 UPPER RESPIRATORY TRACT CONGESTION | 1 0.01 95.04 UPPER RESPIRATORY TRACT INFECTION | 9 0.09 95.13 URETHRAL DISORDER | 1 0.01 95.14 URETHRAL INJURY | 1 0.01 95.15 URETHRAL PAIN | 1 0.01 95.16 URETHRAL SPASM | 1 0.01 95.17 URINARY INCONTINENCE | 11 0.11 95.28 URINARY RETENTION | 8 0.08 95.36 URINARY TRACT INFECTION | 40 0.40 95.76 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 95.77 URINE ABNORMALITY | 1 0.01 95.78 URINE ODOUR ABNORMAL | 2 0.02 95.80 URINE OUTPUT DECREASED | 5 0.05 95.85 URINE OUTPUT INCREASED | 1 0.01 95.86 UROSEPSIS | 1 0.01 95.87 URTICARIA | 20 0.20 96.07 UTERINE CANCER | 1 0.01 96.08 UTERINE CERVICAL SQUAMOUS METAPLASIA | 1 0.01 96.09 UTERINE CONTRACTIONS DURING PREGNANCY | 1 0.01 96.10 UTERINE DILATION AND CURETTAGE | 1 0.01 96.11 UTERINE DISORDER | 3 0.03 96.14 UTERINE ENLARGEMENT | 1 0.01 96.15 UTERINE HAEMORRHAGE | 2 0.02 96.17 UTERINE LEIOMYOMA | 1 0.01 96.18 UTERINE PERFORATION | 1 0.01 96.19 UTERINE POLYP | 1 0.01 96.20 UTERINE PROLAPSE | 1 0.01 96.21 UVEITIS | 2 0.02 96.23 UVEITIS-GLAUCOMA-HYPHAEMA SYNDROME | 1 0.01 96.24 VAGINAL DISCHARGE | 3 0.03 96.27 VAGINAL HAEMORRHAGE | 6 0.06 96.33 VAGINAL INFECTION | 1 0.01 96.34 VARICELLA | 1 0.01 96.35 VARICES OESOPHAGEAL | 2 0.02 96.37 VARICOSE VEIN | 1 0.01 96.38 VASCULAR CALCIFICATION | 1 0.01 96.39 VASCULAR GRAFT | 1 0.01 96.40 VASCULAR PURPURA | 1 0.01 96.41 VASCULITIS | 1 0.01 96.42 VASCULITIS CEREBRAL | 2 0.02 96.44 VASCULITIS NECROTISING | 1 0.01 96.45 VASOSPASM | 1 0.01 96.46 VEIN DISORDER | 2 0.02 96.48 VENOOCCLUSIVE LIVER DISEASE | 3 0.03 96.51 VENOUS INSUFFICIENCY | 1 0.01 96.52 VENOUS THROMBOSIS | 1 0.01 96.53 VENOUS THROMBOSIS LIMB | 1 0.01 96.54 VENTRICULAR EXTRASYSTOLES | 6 0.06 96.60 VENTRICULAR FIBRILLATION | 7 0.07 96.67 VENTRICULAR HYPOKINESIA | 2 0.02 96.69 VENTRICULAR SEPTAL DEFECT | 1 0.01 96.70 VENTRICULAR TACHYARRHYTHMIA | 1 0.01 96.71 VENTRICULAR TACHYCARDIA | 10 0.10 96.81 VERBAL ABUSE | 1 0.01 96.82 VERTEBRAL FORAMINAL STENOSIS | 2 0.02 96.84 VERTIGO | 9 0.09 96.93 VICTIM OF ABUSE | 1 0.01 96.94 VIITH NERVE PARALYSIS | 5 0.05 96.99 VIOLENCE-RELATED SYMPTOM | 1 0.01 97.00 VIRAL INFECTION | 9 0.09 97.09 VIRAL LOAD INCREASED | 2 0.02 97.11 VIROLOGIC FAILURE | 1 0.01 97.12 VISION BLURRED | 16 0.16 97.28 VISUAL ACUITY REDUCED | 13 0.13 97.41 VISUAL FIELD DEFECT | 1 0.01 97.42 VISUAL IMPAIRMENT | 17 0.17 97.59 VITAMIN B1 DEFICIENCY | 1 0.01 97.60 VITAMIN B12 DEFICIENCY | 1 0.01 97.61 VITAMIN D ABNORMAL | 2 0.02 97.63 VITAMIN D DECREASED | 1 0.01 97.64 VITAMIN D DEFICIENCY | 2 0.02 97.66 VITH NERVE PARALYSIS | 1 0.01 97.67 VITILIGO | 1 0.01 97.68 VITREOUS DISORDER | 1 0.01 97.69 VITREOUS FLOATERS | 3 0.03 97.72 VITREOUS HAEMORRHAGE | 1 0.01 97.73 VOCAL CORD DISORDER | 1 0.01 97.74 VOLUME BLOOD DECREASED | 1 0.01 97.75 VOMITING | 77 0.77 98.52 VULVAL DISORDER | 1 0.01 98.53 VULVOVAGINAL BURNING SENSATION | 1 0.01 98.54 VULVOVAGINAL MYCOTIC INFECTION | 1 0.01 98.55 VULVOVAGINAL PAIN | 1 0.01 98.56 VULVOVAGINAL PRURITUS | 1 0.01 98.57 WALKING AID USER | 3 0.03 98.60 WATER INTOXICATION | 1 0.01 98.61 WATERHOUSE-FRIDERICHSEN SYNDROME | 1 0.01 98.62 WAXY FLEXIBILITY | 2 0.02 98.64 WEIGHT BEARING DIFFICULTY | 1 0.01 98.65 WEIGHT DECREASED | 34 0.34 98.99 WEIGHT GAIN POOR | 1 0.01 99.00 WEIGHT INCREASED | 21 0.21 99.21 WEIGHT LOSS POOR | 1 0.01 99.22 WHEELCHAIR USER | 3 0.03 99.25 WHEEZING | 6 0.06 99.31 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.32 WHITE BLOOD CELL COUNT DECREASED | 16 0.16 99.48 WHITE BLOOD CELL COUNT INCREASED | 16 0.16 99.64 WHITE BLOOD CELL DISORDER | 1 0.01 99.65 WITHDRAWAL BLEED | 1 0.01 99.66 WITHDRAWAL SYNDROME | 3 0.03 99.69 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 99.70 WOUND | 2 0.02 99.72 WOUND DEHISCENCE | 2 0.02 99.74 WOUND INFECTION | 1 0.01 99.75 WOUND INFECTION PSEUDOMONAS | 1 0.01 99.76 WRIST FRACTURE | 3 0.03 99.79 WRONG DRUG ADMINISTERED | 2 0.02 99.81 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 17 0.17 99.98 X-RAY LIMB ABNORMAL | 1 0.01 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015